TY  - JOUR
AU  - Senćanski, Dejan
AU  - Marinković, Valentina
AU  - Milošević-Georgiev, Andrijana
AU  - Tadić, Ivana
PY  - 2024
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5550
AB  - Background: Emotional Intelligence (EI) has been recognized by the International Pharmaceutical Federation as a required competency for a pharmacist. This study aimed to compare EI and Perceived Stress (PS) levels in pharmacists who completed the post-graduate specialization program (the Case), and pharmacists who started the program (the Control group). Materials and Methods: Validated instruments measuring EI and PS were distributed online to participating postgraduates or alumni. All complete responses were analyzed; data from participants who had undergone previous EI training were excluded. Comparing the groups, additional EI domains’ subanalysis and their correlations with PS were made. Results: The overall response rate was 67.8%. There was no expected difference between the groups either in EI or in the PS levels, and the overall population reached means of 119.30±12.92 and 17.25±6.46, respectively. The highest EI levels were found in sales and marketing professionals in the pharmaceutical industry and the lowest in clinical pharmacy practitioners. EI and PS were highly negatively correlated (r=-0,543), thus indicating that developing EI may have protective effects against stress. Subanalysis revealed the highest potential for stress-protective effects in the Emotional Self-Management and Emotional Self-Control subdomains (r=-0,528, r=-0,457, respectively). Conclusion: Given the expanded importance of EI development in pharmacy practice, the results of the study could be a basis for the specialization and continuing pharmacist education program creators to evaluate the curricula and propose changes in the methodologies, contents, and approaches in work to meet development needs of post-graduate pharmacists better. Further research should confirm the findings of the EI subanalysis.
PB  - Association of Pharmaceutical Teachers of India
T2  - Indian Journal of Pharmaceutical Education and Research
T1  - Emotional Intelligence and Perceived Stress in Pharmacists Completing Post-Graduate Specialization Programs: A Cross-Sectional Study
VL  - 58
IS  - 2
SP  - 671
EP  - 678
DO  - 10.5530/ijper.58.2.75
ER  - 

@article{
author = "Senćanski, Dejan and Marinković, Valentina and Milošević-Georgiev, Andrijana and Tadić, Ivana",
year = "2024",
abstract = "Background: Emotional Intelligence (EI) has been recognized by the International Pharmaceutical Federation as a required competency for a pharmacist. This study aimed to compare EI and Perceived Stress (PS) levels in pharmacists who completed the post-graduate specialization program (the Case), and pharmacists who started the program (the Control group). Materials and Methods: Validated instruments measuring EI and PS were distributed online to participating postgraduates or alumni. All complete responses were analyzed; data from participants who had undergone previous EI training were excluded. Comparing the groups, additional EI domains’ subanalysis and their correlations with PS were made. Results: The overall response rate was 67.8%. There was no expected difference between the groups either in EI or in the PS levels, and the overall population reached means of 119.30±12.92 and 17.25±6.46, respectively. The highest EI levels were found in sales and marketing professionals in the pharmaceutical industry and the lowest in clinical pharmacy practitioners. EI and PS were highly negatively correlated (r=-0,543), thus indicating that developing EI may have protective effects against stress. Subanalysis revealed the highest potential for stress-protective effects in the Emotional Self-Management and Emotional Self-Control subdomains (r=-0,528, r=-0,457, respectively). Conclusion: Given the expanded importance of EI development in pharmacy practice, the results of the study could be a basis for the specialization and continuing pharmacist education program creators to evaluate the curricula and propose changes in the methodologies, contents, and approaches in work to meet development needs of post-graduate pharmacists better. Further research should confirm the findings of the EI subanalysis.",
publisher = "Association of Pharmaceutical Teachers of India",
journal = "Indian Journal of Pharmaceutical Education and Research",
title = "Emotional Intelligence and Perceived Stress in Pharmacists Completing Post-Graduate Specialization Programs: A Cross-Sectional Study",
volume = "58",
number = "2",
pages = "671-678",
doi = "10.5530/ijper.58.2.75"
}

Senćanski, D., Marinković, V., Milošević-Georgiev, A.,& Tadić, I.. (2024). Emotional Intelligence and Perceived Stress in Pharmacists Completing Post-Graduate Specialization Programs: A Cross-Sectional Study. in Indian Journal of Pharmaceutical Education and Research
Association of Pharmaceutical Teachers of India., 58(2), 671-678.
https://doi.org/10.5530/ijper.58.2.75

Senćanski D, Marinković V, Milošević-Georgiev A, Tadić I. Emotional Intelligence and Perceived Stress in Pharmacists Completing Post-Graduate Specialization Programs: A Cross-Sectional Study. in Indian Journal of Pharmaceutical Education and Research. 2024;58(2):671-678.
doi:10.5530/ijper.58.2.75 .

Senćanski, Dejan, Marinković, Valentina, Milošević-Georgiev, Andrijana, Tadić, Ivana, "Emotional Intelligence and Perceived Stress in Pharmacists Completing Post-Graduate Specialization Programs: A Cross-Sectional Study" in Indian Journal of Pharmaceutical Education and Research, 58, no. 2 (2024):671-678,
https://doi.org/10.5530/ijper.58.2.75 . .

TY  - JOUR
AU  - Lukačišinová, Anna
AU  - Reissigová, Jindra
AU  - Ortner-Hadžiabdić, Maja
AU  - Brkić, Jovana
AU  - Okuyan, Betul
AU  - Volmer, Daisy
AU  - Tadić, Ivana
AU  - Modamio, Pilar
AU  - Mariño, Eduardo
AU  - Tachkov, Konstantine
AU  - Liperotti, Rosa
AU  - Onder, Graziano
AU  - Finne-Soveri, Harriet
AU  - van Hout, Hein
AU  - Howard, Elizabeth P.
AU  - Fialová, Daniela
PY  - 2024
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5563
AB  - Background: The use of benzodiazepines (BZDs) in older population is often accompanied by drug-related complications. Inappropriate BZD use significantly alters older adults’ clinical and functional status. This study compares the prevalence, prescribing patterns and factors associated with BZD use in community-dwelling older patients in 7 European countries. Methods: International, cross-sectional study was conducted in community-dwelling older adults (65 +) in the Czech Republic, Serbia, Estonia, Bulgaria, Croatia, Turkey, and Spain between Feb2019 and Mar2020. Structured and standardized questionnaire based on interRAI assessment scales was applied. Logistic regression was used to evaluate factors associated with BZD use. Results: Out of 2,865 older patients (mean age 73.2 years ± 6.8, 61.2% women) 14.9% were BZD users. The highest prevalence of BZD use was identified in Croatia (35.5%), Spain (33.5%) and Serbia (31.3%). The most frequently prescribed BZDs were diazepam (27.9% of 426 BZD users), alprazolam (23.7%), bromazepam (22.8%) and lorazepam (16.7%). Independent factors associated with BZD use were female gender (OR 1.58, 95%CI 1.19–2.10), hyperpolypharmacy (OR 1.97, 95%CI 1.22–3.16), anxiety (OR 4.26, 95%CI 2.86–6.38), sleeping problems (OR 4.47, 95%CI 3.38–5.92), depression (OR 1.95, 95%CI 1.29–2.95), repetitive anxious complaints (OR 1.77, 95%CI 1.29–2.42), problems with syncope (OR 1.78, 95%CI 1.03–3.06), and loss of appetite (OR 0.60, 95%CI 0.38–0.94). In comparison to Croatia, residing in other countries was associated with lower odds of BZD use (ORs varied from 0.49 (95%CI 0.32–0.75) in Spain to 0.01 (95%CI 0.00–0.03) in Turkey), excluding Serbia (OR 1.11, 95%CI 0.79–1.56). Conclusions: Despite well-known negative effects, BZDs are still frequently prescribed in older outpatient population in European countries. Principles of safer geriatric prescribing and effective deprescribing strategies should be individually applied in older BZD users.
PB  - BioMed Central Ltd
T2  - BMC Geriatrics
T1  - Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries
VL  - 24
IS  - 1
DO  - 10.1186/s12877-024-04742-7
ER  - 

@article{
author = "Lukačišinová, Anna and Reissigová, Jindra and Ortner-Hadžiabdić, Maja and Brkić, Jovana and Okuyan, Betul and Volmer, Daisy and Tadić, Ivana and Modamio, Pilar and Mariño, Eduardo and Tachkov, Konstantine and Liperotti, Rosa and Onder, Graziano and Finne-Soveri, Harriet and van Hout, Hein and Howard, Elizabeth P. and Fialová, Daniela",
year = "2024",
abstract = "Background: The use of benzodiazepines (BZDs) in older population is often accompanied by drug-related complications. Inappropriate BZD use significantly alters older adults’ clinical and functional status. This study compares the prevalence, prescribing patterns and factors associated with BZD use in community-dwelling older patients in 7 European countries. Methods: International, cross-sectional study was conducted in community-dwelling older adults (65 +) in the Czech Republic, Serbia, Estonia, Bulgaria, Croatia, Turkey, and Spain between Feb2019 and Mar2020. Structured and standardized questionnaire based on interRAI assessment scales was applied. Logistic regression was used to evaluate factors associated with BZD use. Results: Out of 2,865 older patients (mean age 73.2 years ± 6.8, 61.2% women) 14.9% were BZD users. The highest prevalence of BZD use was identified in Croatia (35.5%), Spain (33.5%) and Serbia (31.3%). The most frequently prescribed BZDs were diazepam (27.9% of 426 BZD users), alprazolam (23.7%), bromazepam (22.8%) and lorazepam (16.7%). Independent factors associated with BZD use were female gender (OR 1.58, 95%CI 1.19–2.10), hyperpolypharmacy (OR 1.97, 95%CI 1.22–3.16), anxiety (OR 4.26, 95%CI 2.86–6.38), sleeping problems (OR 4.47, 95%CI 3.38–5.92), depression (OR 1.95, 95%CI 1.29–2.95), repetitive anxious complaints (OR 1.77, 95%CI 1.29–2.42), problems with syncope (OR 1.78, 95%CI 1.03–3.06), and loss of appetite (OR 0.60, 95%CI 0.38–0.94). In comparison to Croatia, residing in other countries was associated with lower odds of BZD use (ORs varied from 0.49 (95%CI 0.32–0.75) in Spain to 0.01 (95%CI 0.00–0.03) in Turkey), excluding Serbia (OR 1.11, 95%CI 0.79–1.56). Conclusions: Despite well-known negative effects, BZDs are still frequently prescribed in older outpatient population in European countries. Principles of safer geriatric prescribing and effective deprescribing strategies should be individually applied in older BZD users.",
publisher = "BioMed Central Ltd",
journal = "BMC Geriatrics",
title = "Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries",
volume = "24",
number = "1",
doi = "10.1186/s12877-024-04742-7"
}

Lukačišinová, A., Reissigová, J., Ortner-Hadžiabdić, M., Brkić, J., Okuyan, B., Volmer, D., Tadić, I., Modamio, P., Mariño, E., Tachkov, K., Liperotti, R., Onder, G., Finne-Soveri, H., van Hout, H., Howard, E. P.,& Fialová, D.. (2024). Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries. in BMC Geriatrics
BioMed Central Ltd., 24(1).
https://doi.org/10.1186/s12877-024-04742-7

Lukačišinová A, Reissigová J, Ortner-Hadžiabdić M, Brkić J, Okuyan B, Volmer D, Tadić I, Modamio P, Mariño E, Tachkov K, Liperotti R, Onder G, Finne-Soveri H, van Hout H, Howard EP, Fialová D. Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries. in BMC Geriatrics. 2024;24(1).
doi:10.1186/s12877-024-04742-7 .

Lukačišinová, Anna, Reissigová, Jindra, Ortner-Hadžiabdić, Maja, Brkić, Jovana, Okuyan, Betul, Volmer, Daisy, Tadić, Ivana, Modamio, Pilar, Mariño, Eduardo, Tachkov, Konstantine, Liperotti, Rosa, Onder, Graziano, Finne-Soveri, Harriet, van Hout, Hein, Howard, Elizabeth P., Fialová, Daniela, "Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries" in BMC Geriatrics, 24, no. 1 (2024),
https://doi.org/10.1186/s12877-024-04742-7 . .

TY  - JOUR
AU  - Tadić, Ivana
AU  - Žuža, Olivera
AU  - Žujović, Dejan
AU  - Agić, Anita
AU  - Korčok, Davor
AU  - Lazović, Biljana
AU  - Stevanović, Dejan
AU  - Đorđević, Brižita
PY  - 2024
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5408
AB  - Objectives: Evidence suggests that both N-Acetyl-L-cysteine (NAC) and NAC in combination with propolis (NAC-P) reduce symptoms of acute bronchitis and improve Health-Related Quality of Life (HRQoL). This study aimed to compare the impact of NAC and NAC-P therapy on acute bronchitis patients' quality of life. Design, setting, and subjects: A randomized, single-blind parallel-group study was achieved at Municipal Institute for Lung Diseases and Tuberculosis Medical Centre, Belgrade, Serbia. Patients with acute bronchitis were randomly assigned into two groups to receive NAC (200mg three times a day) or NAC-P (200mg+80mg three times a day) orally for a minimum of ten days. HRQoL of patients was measured twice (at two appointments) using the Leicester Cough Questionnaire (LCQ) and EQ-5D questionnaires. Results: The study included 42 patients in the NAC-P group and 43 in the NAC group. The correlation between the LCQ total score and Health State Values (HSV) was positive and statistically significant in the NAC-P and the NAC groups at the second appointment. The differences between values of EQ-5D scores were slightly higher (but not statistically significant) in the NAC-P group compared to the NAC group, indicating a more remarkable improvement of HRQoL using NAC-P. Conclusion: NAC-P and NAC may improve HRQoL in patients with acute bronchitis. EQ-5D scale values indicated that NAC-P might improve quality of life more than NAC. Our results may provide the basis for better decision-making by healthcare professionals when choosing the right therapy.
PB  - Association of Pharmaceutical Teachers of India
T2  - Indian Journal of Pharmaceutical Education and Research
T1  - The Comparative Analysis of the Impact of N-Acetyl-L-Cysteine and its Combination with Propolis on Quality-of-Life in Patients with Acute Bronchitis
VL  - 58
IS  - 1
SP  - 348
EP  - 354
DO  - 10.5530/ijper.58.1.38
ER  - 

@article{
author = "Tadić, Ivana and Žuža, Olivera and Žujović, Dejan and Agić, Anita and Korčok, Davor and Lazović, Biljana and Stevanović, Dejan and Đorđević, Brižita",
year = "2024",
abstract = "Objectives: Evidence suggests that both N-Acetyl-L-cysteine (NAC) and NAC in combination with propolis (NAC-P) reduce symptoms of acute bronchitis and improve Health-Related Quality of Life (HRQoL). This study aimed to compare the impact of NAC and NAC-P therapy on acute bronchitis patients' quality of life. Design, setting, and subjects: A randomized, single-blind parallel-group study was achieved at Municipal Institute for Lung Diseases and Tuberculosis Medical Centre, Belgrade, Serbia. Patients with acute bronchitis were randomly assigned into two groups to receive NAC (200mg three times a day) or NAC-P (200mg+80mg three times a day) orally for a minimum of ten days. HRQoL of patients was measured twice (at two appointments) using the Leicester Cough Questionnaire (LCQ) and EQ-5D questionnaires. Results: The study included 42 patients in the NAC-P group and 43 in the NAC group. The correlation between the LCQ total score and Health State Values (HSV) was positive and statistically significant in the NAC-P and the NAC groups at the second appointment. The differences between values of EQ-5D scores were slightly higher (but not statistically significant) in the NAC-P group compared to the NAC group, indicating a more remarkable improvement of HRQoL using NAC-P. Conclusion: NAC-P and NAC may improve HRQoL in patients with acute bronchitis. EQ-5D scale values indicated that NAC-P might improve quality of life more than NAC. Our results may provide the basis for better decision-making by healthcare professionals when choosing the right therapy.",
publisher = "Association of Pharmaceutical Teachers of India",
journal = "Indian Journal of Pharmaceutical Education and Research",
title = "The Comparative Analysis of the Impact of N-Acetyl-L-Cysteine and its Combination with Propolis on Quality-of-Life in Patients with Acute Bronchitis",
volume = "58",
number = "1",
pages = "348-354",
doi = "10.5530/ijper.58.1.38"
}

Tadić, I., Žuža, O., Žujović, D., Agić, A., Korčok, D., Lazović, B., Stevanović, D.,& Đorđević, B.. (2024). The Comparative Analysis of the Impact of N-Acetyl-L-Cysteine and its Combination with Propolis on Quality-of-Life in Patients with Acute Bronchitis. in Indian Journal of Pharmaceutical Education and Research
Association of Pharmaceutical Teachers of India., 58(1), 348-354.
https://doi.org/10.5530/ijper.58.1.38

Tadić I, Žuža O, Žujović D, Agić A, Korčok D, Lazović B, Stevanović D, Đorđević B. The Comparative Analysis of the Impact of N-Acetyl-L-Cysteine and its Combination with Propolis on Quality-of-Life in Patients with Acute Bronchitis. in Indian Journal of Pharmaceutical Education and Research. 2024;58(1):348-354.
doi:10.5530/ijper.58.1.38 .

Tadić, Ivana, Žuža, Olivera, Žujović, Dejan, Agić, Anita, Korčok, Davor, Lazović, Biljana, Stevanović, Dejan, Đorđević, Brižita, "The Comparative Analysis of the Impact of N-Acetyl-L-Cysteine and its Combination with Propolis on Quality-of-Life in Patients with Acute Bronchitis" in Indian Journal of Pharmaceutical Education and Research, 58, no. 1 (2024):348-354,
https://doi.org/10.5530/ijper.58.1.38 . .

TY  - CONF
AU  - Jovanović, Aleksandar
AU  - Catić Ðorđević, Aleksandra
AU  - Dimić, Nemanja
AU  - Milošević-Georgiev, Andrijana
AU  - Tadić, Ivana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5493
AB  - Background Urinary tract infections (UTIs) are among the most common bacterial infections, mainly affecting the female population. The annual incidence of UTI in the male population aged 17–79 is 2.2%, while 12% of men reported symptoms of urinary infections at least once. ...
PB  - Springer
C3  - International Journal of Clinical Pharmacy
T1  - Urinary tract health in the male population in the Republic of Serbia—part II
VL  - 45
IS  - 2
SP  - 538
EP  - 538
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5493
ER  - 

@conference{
author = "Jovanović, Aleksandar and Catić Ðorđević, Aleksandra and Dimić, Nemanja and Milošević-Georgiev, Andrijana and Tadić, Ivana",
year = "2023",
abstract = "Background Urinary tract infections (UTIs) are among the most common bacterial infections, mainly affecting the female population. The annual incidence of UTI in the male population aged 17–79 is 2.2%, while 12% of men reported symptoms of urinary infections at least once. ...",
publisher = "Springer",
journal = "International Journal of Clinical Pharmacy",
title = "Urinary tract health in the male population in the Republic of Serbia—part II",
volume = "45",
number = "2",
pages = "538-538",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5493"
}

Jovanović, A., Catić Ðorđević, A., Dimić, N., Milošević-Georgiev, A.,& Tadić, I.. (2023). Urinary tract health in the male population in the Republic of Serbia—part II. in International Journal of Clinical Pharmacy
Springer., 45(2), 538-538.
https://hdl.handle.net/21.15107/rcub_farfar_5493

Jovanović A, Catić Ðorđević A, Dimić N, Milošević-Georgiev A, Tadić I. Urinary tract health in the male population in the Republic of Serbia—part II. in International Journal of Clinical Pharmacy. 2023;45(2):538-538.
https://hdl.handle.net/21.15107/rcub_farfar_5493 .

Jovanović, Aleksandar, Catić Ðorđević, Aleksandra, Dimić, Nemanja, Milošević-Georgiev, Andrijana, Tadić, Ivana, "Urinary tract health in the male population in the Republic of Serbia—part II" in International Journal of Clinical Pharmacy, 45, no. 2 (2023):538-538,
https://hdl.handle.net/21.15107/rcub_farfar_5493 .

TY  - CONF
AU  - Jovanović, Aleksandar
AU  - Dimić, Nemanja
AU  - Catić Ðorđević, Aleksandra
AU  - Tadić, Ivana
AU  - Milošević-Georgiev, Andrijana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5492
AB  - Background Lower urinary tract symptoms (LUTS) significantly affect the quality of life of men, with a prevalence of 60% to 84%, which increases with age. However, a relatively small percentage of affected men seek advice or treatment for their symptoms. ...
PB  - Springer
C3  - International Journal of Clinical Pharmacy
T1  - Urinary tract health in the male population in the Republic of Serbia—part I
VL  - 45
IS  - 2
SP  - 537
EP  - 537
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5492
ER  - 

@conference{
author = "Jovanović, Aleksandar and Dimić, Nemanja and Catić Ðorđević, Aleksandra and Tadić, Ivana and Milošević-Georgiev, Andrijana",
year = "2023",
abstract = "Background Lower urinary tract symptoms (LUTS) significantly affect the quality of life of men, with a prevalence of 60% to 84%, which increases with age. However, a relatively small percentage of affected men seek advice or treatment for their symptoms. ...",
publisher = "Springer",
journal = "International Journal of Clinical Pharmacy",
title = "Urinary tract health in the male population in the Republic of Serbia—part I",
volume = "45",
number = "2",
pages = "537-537",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5492"
}

Jovanović, A., Dimić, N., Catić Ðorđević, A., Tadić, I.,& Milošević-Georgiev, A.. (2023). Urinary tract health in the male population in the Republic of Serbia—part I. in International Journal of Clinical Pharmacy
Springer., 45(2), 537-537.
https://hdl.handle.net/21.15107/rcub_farfar_5492

Jovanović A, Dimić N, Catić Ðorđević A, Tadić I, Milošević-Georgiev A. Urinary tract health in the male population in the Republic of Serbia—part I. in International Journal of Clinical Pharmacy. 2023;45(2):537-537.
https://hdl.handle.net/21.15107/rcub_farfar_5492 .

Jovanović, Aleksandar, Dimić, Nemanja, Catić Ðorđević, Aleksandra, Tadić, Ivana, Milošević-Georgiev, Andrijana, "Urinary tract health in the male population in the Republic of Serbia—part I" in International Journal of Clinical Pharmacy, 45, no. 2 (2023):537-537,
https://hdl.handle.net/21.15107/rcub_farfar_5492 .

TY  - CONF
AU  - Jovanović, Aleksandar
AU  - Kundalić, Ana
AU  - Miladinović, Bojana
AU  - Džodić, Predrag
AU  - Catić-Đorđević, Aleksandra
AU  - Krajnović, Dušanka
AU  - Tadić, Ivana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5352
AB  - Kao jedan od najvećih javnozdravstvenih izazova diabetes mellitus predstavlja razlog
konstantnog unapređenja farmakoterapije (1). Savremena terapija diabetes mellitus-a može
promeniti tok bolesti, prevenirati komplikacije i doprineti uštedi u zdravstvu (2). Cilj rada bio je da
se analizira potrošnja antidijabetika u Srbiji, u periodu od 2012. do 2021. godine i usklađenost sa
preporukama Nacionalnog vodiča. Podaci o potrošnji antidijabetika prikupljeni su iz publikacija
Agencije za lekove i medicinska sredstva Srbije. Za svaki internacionalni nezaštićen naziv (INN),
praćena je potrošnja izražena u standardizovanoj jedinici - definisanoj dnevnoj dozi na 1000
stanovnika u danu (DDD/1000 stanovnika/dan). Najveća potrošnja antidijabetika tokom ispitivanog
perioda primećena je 2020. godine, dok je najniža bila 2012. godine. Potrošnja antidijabetika u 2021.
godini iznosila je 92,18 DDD/1000 stanovnika/dan što je za 23,73% više u odnosu na 2012. godinu.
Među ovom grupom lekova dominira upotreba oralnih antidijabetika koji se u proseku primenjuju
4,45 puta više u odnosu na insulin i analoge. Najzastupljeniji lekovi u ukupnoj potrošnji antidijabetika
do 2017. godine bili su sulfonamidi i derivati sulfonilureje kada su u proseku činili 43,39%. Nakon
2017. godine prvo mesto po potrošnji zauzima metformin, čiji udeo u ukupnoj potrošnji
antidijabetika dostiže 48,75% u 2021. godini. Potrošnja novih oralnih antidijabetika je veoma mala i
ne prelazi 0,1% ukupne potrošnje tokom ispitivanog perioda. Ipak najveći porast je primećen u
upotrebi inhibitora natrijum-glukoznog kotransportera 2 (SGLT2) (3,19 DDD/1000 stanovnika/dan
u 2021. godini nasuprot 0,001 DDD/1000 stanovnika/dan u 2015. godini). Rastući trend potrošnje
posebno je izražen kod metformina i SGLT2 inhibitora. Rezultati ukazuju na usklađenost primene
antidijabetika sa preporukama Nacionalnog vodiča.
AB  - As one of the biggest public health challenges, diabetes mellitus represents the reason for the
constant pharmacotherapy improvement (1). Modern therapy of diabetes mellitus can alter the
course of the disease, prevent complications, and contribute to healthcare savings (2). This study
aimed to analyze the consumption of antidiabetic drugs in the Republic of Serbia from 2012 to 2021
and compliance with the recommendations of the National Guide. The consumption of all registered
antidiabetic drugs was obtained from publications of the Medicines and Medical Devices Agency of
Serbia. For each International Nonproprietary Name (INN), consumption was monitored and
expressed in a standardized unit-defined daily dose per 1000 inhabitants per day (DDD/1000
inhabitants/day). During the study period, the highest consumption was observed in 2020, while the
lowest was in 2012. Antidiabetic drug consumption in 2021 amounted to 92.18 DDD/1000
inhabitants/day, which is 23.73% higher compared to 2012. The consumption of oral antidiabetics
was dominant, on average 4.45 times more than insulin and analogs. The most commonly used drugs
until 2017 in total antidiabetic consumption were sulfonylureas and sulfonylurea derivatives,
constituting an average of 43.39%. After 2017, metformin took the lead in consumption, reaching
48.75% of total antidiabetic consumption in 2021. New oral antidiabetic drugs do not exceed 0.1%
of the total consumption during the examined period. However, sodium-glucose cotransporter-2
(SGLT2) inhibitors (3.19 DDD/1000 inhabitants/day in 2021 compared to 0.001 DDD/1000
inhabitants/day in 2015) noted the most significant increase. The increasing consumption trend is
particularly pronounced for metformin and SGLT2 inhibitors. The results indicate compliance in the
use of antidiabetic drugs with the National Guide recommendations.
PB  - Savez farmaceutskih udruženja Srbije
C3  - Arhiv za farmaciju
T1  - Dijabetes u Srbiji: trendovi u potrošnji antidijabetika od 2012. do 2021. godine
T1  - Diabetes in Serbia: trends in antidiabetic drug consumption from 2012 to 2021
VL  - 73
IS  - Suppl. 4
SP  - S51
EP  - S52
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5352
ER  - 

@conference{
author = "Jovanović, Aleksandar and Kundalić, Ana and Miladinović, Bojana and Džodić, Predrag and Catić-Đorđević, Aleksandra and Krajnović, Dušanka and Tadić, Ivana",
year = "2023",
abstract = "Kao jedan od najvećih javnozdravstvenih izazova diabetes mellitus predstavlja razlog
konstantnog unapređenja farmakoterapije (1). Savremena terapija diabetes mellitus-a može
promeniti tok bolesti, prevenirati komplikacije i doprineti uštedi u zdravstvu (2). Cilj rada bio je da
se analizira potrošnja antidijabetika u Srbiji, u periodu od 2012. do 2021. godine i usklađenost sa
preporukama Nacionalnog vodiča. Podaci o potrošnji antidijabetika prikupljeni su iz publikacija
Agencije za lekove i medicinska sredstva Srbije. Za svaki internacionalni nezaštićen naziv (INN),
praćena je potrošnja izražena u standardizovanoj jedinici - definisanoj dnevnoj dozi na 1000
stanovnika u danu (DDD/1000 stanovnika/dan). Najveća potrošnja antidijabetika tokom ispitivanog
perioda primećena je 2020. godine, dok je najniža bila 2012. godine. Potrošnja antidijabetika u 2021.
godini iznosila je 92,18 DDD/1000 stanovnika/dan što je za 23,73% više u odnosu na 2012. godinu.
Među ovom grupom lekova dominira upotreba oralnih antidijabetika koji se u proseku primenjuju
4,45 puta više u odnosu na insulin i analoge. Najzastupljeniji lekovi u ukupnoj potrošnji antidijabetika
do 2017. godine bili su sulfonamidi i derivati sulfonilureje kada su u proseku činili 43,39%. Nakon
2017. godine prvo mesto po potrošnji zauzima metformin, čiji udeo u ukupnoj potrošnji
antidijabetika dostiže 48,75% u 2021. godini. Potrošnja novih oralnih antidijabetika je veoma mala i
ne prelazi 0,1% ukupne potrošnje tokom ispitivanog perioda. Ipak najveći porast je primećen u
upotrebi inhibitora natrijum-glukoznog kotransportera 2 (SGLT2) (3,19 DDD/1000 stanovnika/dan
u 2021. godini nasuprot 0,001 DDD/1000 stanovnika/dan u 2015. godini). Rastući trend potrošnje
posebno je izražen kod metformina i SGLT2 inhibitora. Rezultati ukazuju na usklađenost primene
antidijabetika sa preporukama Nacionalnog vodiča., As one of the biggest public health challenges, diabetes mellitus represents the reason for the
constant pharmacotherapy improvement (1). Modern therapy of diabetes mellitus can alter the
course of the disease, prevent complications, and contribute to healthcare savings (2). This study
aimed to analyze the consumption of antidiabetic drugs in the Republic of Serbia from 2012 to 2021
and compliance with the recommendations of the National Guide. The consumption of all registered
antidiabetic drugs was obtained from publications of the Medicines and Medical Devices Agency of
Serbia. For each International Nonproprietary Name (INN), consumption was monitored and
expressed in a standardized unit-defined daily dose per 1000 inhabitants per day (DDD/1000
inhabitants/day). During the study period, the highest consumption was observed in 2020, while the
lowest was in 2012. Antidiabetic drug consumption in 2021 amounted to 92.18 DDD/1000
inhabitants/day, which is 23.73% higher compared to 2012. The consumption of oral antidiabetics
was dominant, on average 4.45 times more than insulin and analogs. The most commonly used drugs
until 2017 in total antidiabetic consumption were sulfonylureas and sulfonylurea derivatives,
constituting an average of 43.39%. After 2017, metformin took the lead in consumption, reaching
48.75% of total antidiabetic consumption in 2021. New oral antidiabetic drugs do not exceed 0.1%
of the total consumption during the examined period. However, sodium-glucose cotransporter-2
(SGLT2) inhibitors (3.19 DDD/1000 inhabitants/day in 2021 compared to 0.001 DDD/1000
inhabitants/day in 2015) noted the most significant increase. The increasing consumption trend is
particularly pronounced for metformin and SGLT2 inhibitors. The results indicate compliance in the
use of antidiabetic drugs with the National Guide recommendations.",
publisher = "Savez farmaceutskih udruženja Srbije",
journal = "Arhiv za farmaciju",
title = "Dijabetes u Srbiji: trendovi u potrošnji antidijabetika od 2012. do 2021. godine, Diabetes in Serbia: trends in antidiabetic drug consumption from 2012 to 2021",
volume = "73",
number = "Suppl. 4",
pages = "S51-S52",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5352"
}

Jovanović, A., Kundalić, A., Miladinović, B., Džodić, P., Catić-Đorđević, A., Krajnović, D.,& Tadić, I.. (2023). Dijabetes u Srbiji: trendovi u potrošnji antidijabetika od 2012. do 2021. godine. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije., 73(Suppl. 4), S51-S52.
https://hdl.handle.net/21.15107/rcub_farfar_5352

Jovanović A, Kundalić A, Miladinović B, Džodić P, Catić-Đorđević A, Krajnović D, Tadić I. Dijabetes u Srbiji: trendovi u potrošnji antidijabetika od 2012. do 2021. godine. in Arhiv za farmaciju. 2023;73(Suppl. 4):S51-S52.
https://hdl.handle.net/21.15107/rcub_farfar_5352 .

Jovanović, Aleksandar, Kundalić, Ana, Miladinović, Bojana, Džodić, Predrag, Catić-Đorđević, Aleksandra, Krajnović, Dušanka, Tadić, Ivana, "Dijabetes u Srbiji: trendovi u potrošnji antidijabetika od 2012. do 2021. godine" in Arhiv za farmaciju, 73, no. Suppl. 4 (2023):S51-S52,
https://hdl.handle.net/21.15107/rcub_farfar_5352 .

TY  - CONF
AU  - Jovanović, Aleksandar
AU  - Stefanović-Vojinović, Jelena
AU  - Petrović, Silvana
AU  - Drobac, Milica
AU  - Tadić, Ivana
AU  - Catić-Đorđević, Aleksandra
AU  - Kukić-Marković, Jelena
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5042
AB  - Background: Although the use of medicinal plants have been known since ancient times, an increased use of herbal products is evident in the last few decades, mainly as a part of self-care treatments. In addition to the positive health effects, the use of herbal products can cause certain side effects as well as interactions with conventional therapy, especially among elderly patients.
Purpose: To examine the awareness, habits and attitudes of elderly patients towards the use of herbal products in the Republic of Serbia.
Method: The quantitative, non-experimental research was conducted using a questionnaire in public pharmacies during February 2020. Patients older than 60 years were included in the study. The study was anonymous, and patients gave informed consent.
Results: The study involved 436 patients, of whom 62.4% were female. Most of the respondents live in the city (72.9%) and have a high school or lower education degree (61.9%). Most patients (32.3%) use herbal products daily, while only 12.1% rarely or never use them. Every fourth patient (24.5%) uses them for treatment, while 69.5% to improve their health. Although the majority of patients purchase herbal products in pharmacies and in health food stores (53.6% and 20.8%, respectively), a significant number (19.3%) collect medicinal plants and prepare herbal preparations themselves. The main sources of information about medicinal plants / herbal products are pharmacists (39.7%) and people from the immediate area (28.4%), followed by the media (18.2%) and physicians (11.1%). Every fourth patient (24.5%) uses herbal products for the treatment of some health issues, while 69.5% of patients use herbal products to improve their health. 48.9% of them believe that herbal products are safe, but with some side effects, while 35.8% believe herbal products are completely free of any side effects. Half of respondents (51.4%) believe that herbal products are as effective as or more effective than synthetic medicines. Less than one-third of patients (29.8%) indicated that they knew the difference between herbal medicinal products and herbal dietary supplements. Still, a third of patients (36.7%) needed additional explanations for the use of herbal products. 76.6% of patients stated that they always receive advice from a pharmacist when purchasing herbal products.
Conclusion: The survey conducted in this work showed that elderly patients use herbal products to a considerable extent, which means that it is necessary to educate elderly patients on this matter. Pharmacists should play a vital role in this process and actively discuss the characteristics and proper use of herbal products with patients, especially having in mind the high possibility of interactions with conventional medicines and occurrence of side effects. Since the quality of some herbal products sometimes could be questionable, especially non-regulated ones, patients should be encouraged to purchase them from pharmacies and consult with pharmacists.
PB  - The International Pharmaceutical Federation (FIP)
C3  - Pharmacy Education
T1  - Awareness of elderly patients on herbal products in Serbia
VL  - 23
IS  - 5
SP  - 29
EP  - 29
DO  - 10.46542/pe.2023.235.138
ER  - 

@conference{
author = "Jovanović, Aleksandar and Stefanović-Vojinović, Jelena and Petrović, Silvana and Drobac, Milica and Tadić, Ivana and Catić-Đorđević, Aleksandra and Kukić-Marković, Jelena",
year = "2023",
abstract = "Background: Although the use of medicinal plants have been known since ancient times, an increased use of herbal products is evident in the last few decades, mainly as a part of self-care treatments. In addition to the positive health effects, the use of herbal products can cause certain side effects as well as interactions with conventional therapy, especially among elderly patients.
Purpose: To examine the awareness, habits and attitudes of elderly patients towards the use of herbal products in the Republic of Serbia.
Method: The quantitative, non-experimental research was conducted using a questionnaire in public pharmacies during February 2020. Patients older than 60 years were included in the study. The study was anonymous, and patients gave informed consent.
Results: The study involved 436 patients, of whom 62.4% were female. Most of the respondents live in the city (72.9%) and have a high school or lower education degree (61.9%). Most patients (32.3%) use herbal products daily, while only 12.1% rarely or never use them. Every fourth patient (24.5%) uses them for treatment, while 69.5% to improve their health. Although the majority of patients purchase herbal products in pharmacies and in health food stores (53.6% and 20.8%, respectively), a significant number (19.3%) collect medicinal plants and prepare herbal preparations themselves. The main sources of information about medicinal plants / herbal products are pharmacists (39.7%) and people from the immediate area (28.4%), followed by the media (18.2%) and physicians (11.1%). Every fourth patient (24.5%) uses herbal products for the treatment of some health issues, while 69.5% of patients use herbal products to improve their health. 48.9% of them believe that herbal products are safe, but with some side effects, while 35.8% believe herbal products are completely free of any side effects. Half of respondents (51.4%) believe that herbal products are as effective as or more effective than synthetic medicines. Less than one-third of patients (29.8%) indicated that they knew the difference between herbal medicinal products and herbal dietary supplements. Still, a third of patients (36.7%) needed additional explanations for the use of herbal products. 76.6% of patients stated that they always receive advice from a pharmacist when purchasing herbal products.
Conclusion: The survey conducted in this work showed that elderly patients use herbal products to a considerable extent, which means that it is necessary to educate elderly patients on this matter. Pharmacists should play a vital role in this process and actively discuss the characteristics and proper use of herbal products with patients, especially having in mind the high possibility of interactions with conventional medicines and occurrence of side effects. Since the quality of some herbal products sometimes could be questionable, especially non-regulated ones, patients should be encouraged to purchase them from pharmacies and consult with pharmacists.",
publisher = "The International Pharmaceutical Federation (FIP)",
journal = "Pharmacy Education",
title = "Awareness of elderly patients on herbal products in Serbia",
volume = "23",
number = "5",
pages = "29-29",
doi = "10.46542/pe.2023.235.138"
}

Jovanović, A., Stefanović-Vojinović, J., Petrović, S., Drobac, M., Tadić, I., Catić-Đorđević, A.,& Kukić-Marković, J.. (2023). Awareness of elderly patients on herbal products in Serbia. in Pharmacy Education
The International Pharmaceutical Federation (FIP)., 23(5), 29-29.
https://doi.org/10.46542/pe.2023.235.138

Jovanović A, Stefanović-Vojinović J, Petrović S, Drobac M, Tadić I, Catić-Đorđević A, Kukić-Marković J. Awareness of elderly patients on herbal products in Serbia. in Pharmacy Education. 2023;23(5):29-29.
doi:10.46542/pe.2023.235.138 .

Jovanović, Aleksandar, Stefanović-Vojinović, Jelena, Petrović, Silvana, Drobac, Milica, Tadić, Ivana, Catić-Đorđević, Aleksandra, Kukić-Marković, Jelena, "Awareness of elderly patients on herbal products in Serbia" in Pharmacy Education, 23, no. 5 (2023):29-29,
https://doi.org/10.46542/pe.2023.235.138 . .

TY  - CONF
AU  - Jocić, Dragana
AU  - Krajnović, Dušanka
AU  - Tadić, Ivana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4866
PB  - Springer
C3  - International Journal of Clinical Pharmacy
T1  - Community pharmacists’ stress: factors of influence—variation over time
VL  - 45
SP  - 526
EP  - 527
DO  - 10.1007/s11096-023-01576-y
ER  - 

@conference{
author = "Jocić, Dragana and Krajnović, Dušanka and Tadić, Ivana",
year = "2023",
publisher = "Springer",
journal = "International Journal of Clinical Pharmacy",
title = "Community pharmacists’ stress: factors of influence—variation over time",
volume = "45",
pages = "526-527",
doi = "10.1007/s11096-023-01576-y"
}

Jocić, D., Krajnović, D.,& Tadić, I.. (2023). Community pharmacists’ stress: factors of influence—variation over time. in International Journal of Clinical Pharmacy
Springer., 45, 526-527.
https://doi.org/10.1007/s11096-023-01576-y

Jocić D, Krajnović D, Tadić I. Community pharmacists’ stress: factors of influence—variation over time. in International Journal of Clinical Pharmacy. 2023;45:526-527.
doi:10.1007/s11096-023-01576-y .

Jocić, Dragana, Krajnović, Dušanka, Tadić, Ivana, "Community pharmacists’ stress: factors of influence—variation over time" in International Journal of Clinical Pharmacy, 45 (2023):526-527,
https://doi.org/10.1007/s11096-023-01576-y . .

TY  - GEN
AU  - Rajković, Dragana
AU  - Filipić, Brankica
AU  - Tadić, Ivana
AU  - Rakić, Milan
AU  - Trunić, Marina
AU  - Letić, Bojana
AU  - Stojiljković, Dragana
AU  - Urošević, Jasna
AU  - Šipetić, Tatjana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5117
AB  - Uvod: Na osnovu podataka iz 2020, u Republici Srbiji je kod 1205 žena postavljena dijagnoza karcinoma grlića materice, dok su 643 žene preminule od ove bolesti. Karcinom grlića materice je peti po učestalosti karcinom kod žena u Srbiji i drugi po učestalosti karcinom kod žena između 15 i 44 godina starosti. ...
PB  - Farmaceutska komora Crne Gore
T2  - 4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023 Budva, Bečići, Crna Gora
T1  - Jačanje uloge farmaceuta u promociji značaja HPV vakcinacije u Srbiji na nacionalnom i regionalnom nivou
SP  - 44
EP  - 44
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5117
ER  - 

@misc{
author = "Rajković, Dragana and Filipić, Brankica and Tadić, Ivana and Rakić, Milan and Trunić, Marina and Letić, Bojana and Stojiljković, Dragana and Urošević, Jasna and Šipetić, Tatjana",
year = "2023",
abstract = "Uvod: Na osnovu podataka iz 2020, u Republici Srbiji je kod 1205 žena postavljena dijagnoza karcinoma grlića materice, dok su 643 žene preminule od ove bolesti. Karcinom grlića materice je peti po učestalosti karcinom kod žena u Srbiji i drugi po učestalosti karcinom kod žena između 15 i 44 godina starosti. ...",
publisher = "Farmaceutska komora Crne Gore",
journal = "4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023 Budva, Bečići, Crna Gora",
title = "Jačanje uloge farmaceuta u promociji značaja HPV vakcinacije u Srbiji na nacionalnom i regionalnom nivou",
pages = "44-44",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5117"
}

Rajković, D., Filipić, B., Tadić, I., Rakić, M., Trunić, M., Letić, B., Stojiljković, D., Urošević, J.,& Šipetić, T.. (2023). Jačanje uloge farmaceuta u promociji značaja HPV vakcinacije u Srbiji na nacionalnom i regionalnom nivou. in 4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023 Budva, Bečići, Crna Gora
Farmaceutska komora Crne Gore., 44-44.
https://hdl.handle.net/21.15107/rcub_farfar_5117

Rajković D, Filipić B, Tadić I, Rakić M, Trunić M, Letić B, Stojiljković D, Urošević J, Šipetić T. Jačanje uloge farmaceuta u promociji značaja HPV vakcinacije u Srbiji na nacionalnom i regionalnom nivou. in 4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023 Budva, Bečići, Crna Gora. 2023;:44-44.
https://hdl.handle.net/21.15107/rcub_farfar_5117 .

Rajković, Dragana, Filipić, Brankica, Tadić, Ivana, Rakić, Milan, Trunić, Marina, Letić, Bojana, Stojiljković, Dragana, Urošević, Jasna, Šipetić, Tatjana, "Jačanje uloge farmaceuta u promociji značaja HPV vakcinacije u Srbiji na nacionalnom i regionalnom nivou" in 4. kongres farmaceuta Crne Gore sa međunarodnim učešćem, 11-14. maj 2023 Budva, Bečići, Crna Gora (2023):44-44,
https://hdl.handle.net/21.15107/rcub_farfar_5117 .

TY  - JOUR
AU  - Tomić, Tanja
AU  - Henman, Martin
AU  - Tadić, Ivana
AU  - Antić-Stanković, Jelena
AU  - Santric Milicević, Milena
AU  - Maksimović, Nataša
AU  - Odalović, Marina
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4832
AB  - Background In Europe, Serbia occupies a high position in antibiotic utilization and antimicrobial resistance (AMR). Aim The aim was to analyse utilization trends of meropenem, ceftazidime, aminoglycosides, piperacillin/tazobactam and fluoroquinolones (2006–2020), and the reported AMR in Pseudomonas aeruginosa (2013–2020) in Serbia and to compare with data from eight European countries (2015–2020). Method Joinpoint regression was used to analyse antibiotic utilization data (2006–2020) and the reported AMR in Pseu- domonas aeruginosa (2013–2020). Data sources were relevant national and international institutions. Antibiotic utilization and AMR in Pseudomonas aeruginosa data in Serbia were compared with eight European countries. Results There was a significantly increased trend for ceftazidime utilization and reported resistance in Pseudomonas aer- uginosa, Serbia (p < 0.05) (2018–2020). For ceftazidime, piperacillin/tazobactam, and fluoroquinolones resistances in Pseu- domonas aeruginosa an increased trend was observed, Serbia (2013–2020). A decrease in both the utilization of aminogly- cosides, Serbia (p < 0.05) (2006–2018) and contemporaneous Pseudomonas aeruginosa resistance (p > 0.05) was detected. Fluoroquinolone utilization (2015–2020) was highest in Serbia compared to Netherlands and Finland, 310 and 305% higher, similar compared to Romania, and 2% less compared to Montenegro. Aminoglycosides (2015–2020) were 2550 and 783% more used in Serbia compared to Finland and Netherlands, and 38% less regarding Montenegro. The highest percentage of Pseudomonas aeruginosa resistance was in Romania and Serbia (2015–2020). Conclusion The use of piperacillin/tazobactam, ceftazidime and fluoroquinolones should be carefully monitored in clinical practice due to increased Pseudomonas aeruginosa resistance. The level of utilization and AMR in Pseudomonas aeruginosa is still high in Serbia compared to other European countries.
PB  - Springer
T2  - International Journal of Clinical Pharmacy
T1  - Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries
DO  - 10.1007/s11096-023-01603-y
ER  - 

@article{
author = "Tomić, Tanja and Henman, Martin and Tadić, Ivana and Antić-Stanković, Jelena and Santric Milicević, Milena and Maksimović, Nataša and Odalović, Marina",
year = "2023",
abstract = "Background In Europe, Serbia occupies a high position in antibiotic utilization and antimicrobial resistance (AMR). Aim The aim was to analyse utilization trends of meropenem, ceftazidime, aminoglycosides, piperacillin/tazobactam and fluoroquinolones (2006–2020), and the reported AMR in Pseudomonas aeruginosa (2013–2020) in Serbia and to compare with data from eight European countries (2015–2020). Method Joinpoint regression was used to analyse antibiotic utilization data (2006–2020) and the reported AMR in Pseu- domonas aeruginosa (2013–2020). Data sources were relevant national and international institutions. Antibiotic utilization and AMR in Pseudomonas aeruginosa data in Serbia were compared with eight European countries. Results There was a significantly increased trend for ceftazidime utilization and reported resistance in Pseudomonas aer- uginosa, Serbia (p < 0.05) (2018–2020). For ceftazidime, piperacillin/tazobactam, and fluoroquinolones resistances in Pseu- domonas aeruginosa an increased trend was observed, Serbia (2013–2020). A decrease in both the utilization of aminogly- cosides, Serbia (p < 0.05) (2006–2018) and contemporaneous Pseudomonas aeruginosa resistance (p > 0.05) was detected. Fluoroquinolone utilization (2015–2020) was highest in Serbia compared to Netherlands and Finland, 310 and 305% higher, similar compared to Romania, and 2% less compared to Montenegro. Aminoglycosides (2015–2020) were 2550 and 783% more used in Serbia compared to Finland and Netherlands, and 38% less regarding Montenegro. The highest percentage of Pseudomonas aeruginosa resistance was in Romania and Serbia (2015–2020). Conclusion The use of piperacillin/tazobactam, ceftazidime and fluoroquinolones should be carefully monitored in clinical practice due to increased Pseudomonas aeruginosa resistance. The level of utilization and AMR in Pseudomonas aeruginosa is still high in Serbia compared to other European countries.",
publisher = "Springer",
journal = "International Journal of Clinical Pharmacy",
title = "Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries",
doi = "10.1007/s11096-023-01603-y"
}

Tomić, T., Henman, M., Tadić, I., Antić-Stanković, J., Santric Milicević, M., Maksimović, N.,& Odalović, M.. (2023). Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries. in International Journal of Clinical Pharmacy
Springer..
https://doi.org/10.1007/s11096-023-01603-y

Tomić T, Henman M, Tadić I, Antić-Stanković J, Santric Milicević M, Maksimović N, Odalović M. Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries. in International Journal of Clinical Pharmacy. 2023;.
doi:10.1007/s11096-023-01603-y .

Tomić, Tanja, Henman, Martin, Tadić, Ivana, Antić-Stanković, Jelena, Santric Milicević, Milena, Maksimović, Nataša, Odalović, Marina, "Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries" in International Journal of Clinical Pharmacy (2023),
https://doi.org/10.1007/s11096-023-01603-y . .

TY  - JOUR
AU  - Senćanski, Dejan
AU  - Marinković, Valentina
AU  - Tadić, Ivana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4432
AB  - Background: Community pharmacists contribute substantially to public health and person-centred care. Emotional intelligence (EI) may help health professionals better engage with patients, handle stress in challenging situations and, presumably, better introduce and implement new services. Aim: The study's aims were to compare the EI and perceived stress (PS) levels of community pharmacists who provided a new service to patients with diabetes with their controls who provided standard pharmaceutical services and to test the correlations between the two constructs. Method: This study used a survey methodology. Well-validated instruments were distributed electronically to all participating pharmacists. To compare the continuous EI and PS data between the two study groups, the paired-samples t test was used. Pearson and Spearman’s correlations were used to test the associations between EI and PS and their respective subdomains. Results: A total of 86 pharmacists participated in the study (n = 43 in each group). The study groups did not differ by any characteristic except gender. Their mean EI and PS levels were 120.95 ± 11.53 and 17.45 ± 4.55, respectively, with no difference between the groups. In both study groups, inverse correlations were found between PS and EI levels, with statistical significance in the control group and in the overall study population (r = − 0.611 and r = − 0.370, respectively). Conclusion: Our results suggest that the introduction of the EI agenda into certification programmes for new community pharmacy services should be considered. The results also suggest that higher EI may have protective effects against PS. Additional research would clarify the need to invest more in such programmes.
PB  - Springer Nature
T2  - International Journal of Clinical Pharmacy
T1  - A cross-sectional study comparing emotional intelligence and perceived stress amongst community pharmacists delivering and not delivering a new service
DO  - 10.1007/s11096-023-01542-8
ER  - 

@article{
author = "Senćanski, Dejan and Marinković, Valentina and Tadić, Ivana",
year = "2023",
abstract = "Background: Community pharmacists contribute substantially to public health and person-centred care. Emotional intelligence (EI) may help health professionals better engage with patients, handle stress in challenging situations and, presumably, better introduce and implement new services. Aim: The study's aims were to compare the EI and perceived stress (PS) levels of community pharmacists who provided a new service to patients with diabetes with their controls who provided standard pharmaceutical services and to test the correlations between the two constructs. Method: This study used a survey methodology. Well-validated instruments were distributed electronically to all participating pharmacists. To compare the continuous EI and PS data between the two study groups, the paired-samples t test was used. Pearson and Spearman’s correlations were used to test the associations between EI and PS and their respective subdomains. Results: A total of 86 pharmacists participated in the study (n = 43 in each group). The study groups did not differ by any characteristic except gender. Their mean EI and PS levels were 120.95 ± 11.53 and 17.45 ± 4.55, respectively, with no difference between the groups. In both study groups, inverse correlations were found between PS and EI levels, with statistical significance in the control group and in the overall study population (r = − 0.611 and r = − 0.370, respectively). Conclusion: Our results suggest that the introduction of the EI agenda into certification programmes for new community pharmacy services should be considered. The results also suggest that higher EI may have protective effects against PS. Additional research would clarify the need to invest more in such programmes.",
publisher = "Springer Nature",
journal = "International Journal of Clinical Pharmacy",
title = "A cross-sectional study comparing emotional intelligence and perceived stress amongst community pharmacists delivering and not delivering a new service",
doi = "10.1007/s11096-023-01542-8"
}

Senćanski, D., Marinković, V.,& Tadić, I.. (2023). A cross-sectional study comparing emotional intelligence and perceived stress amongst community pharmacists delivering and not delivering a new service. in International Journal of Clinical Pharmacy
Springer Nature..
https://doi.org/10.1007/s11096-023-01542-8

Senćanski D, Marinković V, Tadić I. A cross-sectional study comparing emotional intelligence and perceived stress amongst community pharmacists delivering and not delivering a new service. in International Journal of Clinical Pharmacy. 2023;.
doi:10.1007/s11096-023-01542-8 .

Senćanski, Dejan, Marinković, Valentina, Tadić, Ivana, "A cross-sectional study comparing emotional intelligence and perceived stress amongst community pharmacists delivering and not delivering a new service" in International Journal of Clinical Pharmacy (2023),
https://doi.org/10.1007/s11096-023-01542-8 . .

TY  - JOUR
AU  - Ilkić, Jovana
AU  - Obradović, Dragiša
AU  - Milošević-Georgiev, Andrijana
AU  - Marinković, Valentina
AU  - Tadić, Ivana
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4401
AB  - This systematic literature review aimed to provide an overview of the characteristics and methods used in studies applying the Disability-Adjusted Life Years (DALY) concept for infectious diseases within European Union (EU)/European Economic Area (EEA)/European Free Trade Association (EFTA) countries and the United Kingdom. Electronic databases and grey literature were searched for articles reporting the assessment of DALY and its components. We considered studies in which researchers performed DALY calculations using primary epidemiological data input sources. We screened 3,053 studies of which 2,948 were excluded and 105 studies met our inclusion criteria. Of these studies, 22 were multi-country and 83 were single-country studies, of which 46 were from the Netherlands. Food- and water-borne diseases were the most frequently studied infectious diseases. Between 2015 and 2022, the number of burden of infectious disease studies was 1.6 times higher compared to that published between 2000 and 2014. Almost all studies (97%) estimated DALYs based on the incidence- and pathogen-based approach and without social weighting functions; however, there was less methodological consensus with regards to the disability weights and life tables that were applied. The number of burden of infectious disease studies undertaken across Europe has increased over time. Development and use of guidelines will promote performing burden of infectious disease studies and facilitate comparability of the results.
PB  - Association of Pharmaceutical Teachers of India
T2  - Indian Journal of Pharmaceutical Education and Research
T1  - Implementation of Telepharmacy Services in Community Pharmacy – Pharmacists’ Perspective in Republic of Serbia
VL  - 57
IS  - 1
SP  - 286
EP  - 294
DO  - 10.5530/001954641895
ER  - 

@article{
author = "Ilkić, Jovana and Obradović, Dragiša and Milošević-Georgiev, Andrijana and Marinković, Valentina and Tadić, Ivana",
year = "2023",
abstract = "This systematic literature review aimed to provide an overview of the characteristics and methods used in studies applying the Disability-Adjusted Life Years (DALY) concept for infectious diseases within European Union (EU)/European Economic Area (EEA)/European Free Trade Association (EFTA) countries and the United Kingdom. Electronic databases and grey literature were searched for articles reporting the assessment of DALY and its components. We considered studies in which researchers performed DALY calculations using primary epidemiological data input sources. We screened 3,053 studies of which 2,948 were excluded and 105 studies met our inclusion criteria. Of these studies, 22 were multi-country and 83 were single-country studies, of which 46 were from the Netherlands. Food- and water-borne diseases were the most frequently studied infectious diseases. Between 2015 and 2022, the number of burden of infectious disease studies was 1.6 times higher compared to that published between 2000 and 2014. Almost all studies (97%) estimated DALYs based on the incidence- and pathogen-based approach and without social weighting functions; however, there was less methodological consensus with regards to the disability weights and life tables that were applied. The number of burden of infectious disease studies undertaken across Europe has increased over time. Development and use of guidelines will promote performing burden of infectious disease studies and facilitate comparability of the results.",
publisher = "Association of Pharmaceutical Teachers of India",
journal = "Indian Journal of Pharmaceutical Education and Research",
title = "Implementation of Telepharmacy Services in Community Pharmacy – Pharmacists’ Perspective in Republic of Serbia",
volume = "57",
number = "1",
pages = "286-294",
doi = "10.5530/001954641895"
}

Ilkić, J., Obradović, D., Milošević-Georgiev, A., Marinković, V.,& Tadić, I.. (2023). Implementation of Telepharmacy Services in Community Pharmacy – Pharmacists’ Perspective in Republic of Serbia. in Indian Journal of Pharmaceutical Education and Research
Association of Pharmaceutical Teachers of India., 57(1), 286-294.
https://doi.org/10.5530/001954641895

Ilkić J, Obradović D, Milošević-Georgiev A, Marinković V, Tadić I. Implementation of Telepharmacy Services in Community Pharmacy – Pharmacists’ Perspective in Republic of Serbia. in Indian Journal of Pharmaceutical Education and Research. 2023;57(1):286-294.
doi:10.5530/001954641895 .

Ilkić, Jovana, Obradović, Dragiša, Milošević-Georgiev, Andrijana, Marinković, Valentina, Tadić, Ivana, "Implementation of Telepharmacy Services in Community Pharmacy – Pharmacists’ Perspective in Republic of Serbia" in Indian Journal of Pharmaceutical Education and Research, 57, no. 1 (2023):286-294,
https://doi.org/10.5530/001954641895 . .

TY  - JOUR
AU  - Tadić, Ivana
AU  - Trajković, Marija
AU  - Tešić, Ivana
AU  - Lakić, Dragana
AU  - Stević, Ivana
AU  - Šesto, Sofija
AU  - Odalović, Marina
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4239
AB  - Stress is one of the most significant factors that can influence the academic
performance of students. To explore the causes of stress in students, the crosssectional
online survey was conducted during semester (in 2019 year) and during
examination period (in 2020 year) period at the University of Belgrade - Faculty of
Pharmacy. The main results indicated that female gender was the most significant
predictor of stress during the examimation period, and the most frequent stress
sources were limited time to prepare exams and/or colloquia. The role of family,
friends, and boyfriend/girlfriend showed to be of great importance in stress reduction
during the semester and especially during the examimation period. The most frequent
manifestations of stress were feeling nervous, tired and worried. For stress reduction
students usually listened to music and talked with friends. Therefore, student’s
obligations and their overall living conditions should be observed comprehensively.
These results may indicate further actions to decrease stress levels in students, and
need for academic environment that may help students to achieve the best academic
performance.
AB  - Stres je jedan od najznačajnijih faktora koji mogu da utiču na akademske performanse studenata.
U cilju ispitivanja uzroka stresa u populaciji studenata Farmaceutskog fakulteta Univerziteta u
Beogradu, sprovedena je studija preseka tokom semestra (u 2019. godini) i ispitnog roka (u
2020. godini), putem onlajn upitnika. Rezultati studije pokazali su da je ženski pol značajni
prediktor stresa tokom ispitnog roka, dok je ograničeno vreme za pripremu ispita/kolokvijuma
najznačajniji uzrok stresa. Porodica, prijatelji i partneri su najznačajniji u smanjenju stresa,
posebno tokom ispitnih rokova. Najčešće manifestacije stresa su osećaj nervoze, umora i
zabrinutosti. U cilju smanjenja stresa studenti sluščaju muziku ili razgovaraju sa prijateljima.
Time obaveze i uslove života studenata treba sveobuhvatno posmatrati. Rezultati ove studije
mogu ukazati na dalje mere i aktivnosti kako bi se umanjio stres kod studenata, kao i na to kakvo
akademsko okruženje treba razviti da bi se poboljšale akademske performanse studenata.
PB  - Faculty of Medical Sciences University of Kragujevac
T2  - Serbian Journal of Experimental and Clinical Research
T1  - Assessment of causes of stress in a pharmacy student population during semester and examination period
T1  - Analiza uzroka stresa u populaciji studenata farmacije tokom semestra i ispitnog roka
DO  - 10.2478/sjecr-2022-0030
ER  - 

@article{
author = "Tadić, Ivana and Trajković, Marija and Tešić, Ivana and Lakić, Dragana and Stević, Ivana and Šesto, Sofija and Odalović, Marina",
year = "2023",
abstract = "Stress is one of the most significant factors that can influence the academic
performance of students. To explore the causes of stress in students, the crosssectional
online survey was conducted during semester (in 2019 year) and during
examination period (in 2020 year) period at the University of Belgrade - Faculty of
Pharmacy. The main results indicated that female gender was the most significant
predictor of stress during the examimation period, and the most frequent stress
sources were limited time to prepare exams and/or colloquia. The role of family,
friends, and boyfriend/girlfriend showed to be of great importance in stress reduction
during the semester and especially during the examimation period. The most frequent
manifestations of stress were feeling nervous, tired and worried. For stress reduction
students usually listened to music and talked with friends. Therefore, student’s
obligations and their overall living conditions should be observed comprehensively.
These results may indicate further actions to decrease stress levels in students, and
need for academic environment that may help students to achieve the best academic
performance., Stres je jedan od najznačajnijih faktora koji mogu da utiču na akademske performanse studenata.
U cilju ispitivanja uzroka stresa u populaciji studenata Farmaceutskog fakulteta Univerziteta u
Beogradu, sprovedena je studija preseka tokom semestra (u 2019. godini) i ispitnog roka (u
2020. godini), putem onlajn upitnika. Rezultati studije pokazali su da je ženski pol značajni
prediktor stresa tokom ispitnog roka, dok je ograničeno vreme za pripremu ispita/kolokvijuma
najznačajniji uzrok stresa. Porodica, prijatelji i partneri su najznačajniji u smanjenju stresa,
posebno tokom ispitnih rokova. Najčešće manifestacije stresa su osećaj nervoze, umora i
zabrinutosti. U cilju smanjenja stresa studenti sluščaju muziku ili razgovaraju sa prijateljima.
Time obaveze i uslove života studenata treba sveobuhvatno posmatrati. Rezultati ove studije
mogu ukazati na dalje mere i aktivnosti kako bi se umanjio stres kod studenata, kao i na to kakvo
akademsko okruženje treba razviti da bi se poboljšale akademske performanse studenata.",
publisher = "Faculty of Medical Sciences University of Kragujevac",
journal = "Serbian Journal of Experimental and Clinical Research",
title = "Assessment of causes of stress in a pharmacy student population during semester and examination period, Analiza uzroka stresa u populaciji studenata farmacije tokom semestra i ispitnog roka",
doi = "10.2478/sjecr-2022-0030"
}

Tadić, I., Trajković, M., Tešić, I., Lakić, D., Stević, I., Šesto, S.,& Odalović, M.. (2023). Assessment of causes of stress in a pharmacy student population during semester and examination period. in Serbian Journal of Experimental and Clinical Research
Faculty of Medical Sciences University of Kragujevac..
https://doi.org/10.2478/sjecr-2022-0030

Tadić I, Trajković M, Tešić I, Lakić D, Stević I, Šesto S, Odalović M. Assessment of causes of stress in a pharmacy student population during semester and examination period. in Serbian Journal of Experimental and Clinical Research. 2023;.
doi:10.2478/sjecr-2022-0030 .

Tadić, Ivana, Trajković, Marija, Tešić, Ivana, Lakić, Dragana, Stević, Ivana, Šesto, Sofija, Odalović, Marina, "Assessment of causes of stress in a pharmacy student population during semester and examination period" in Serbian Journal of Experimental and Clinical Research (2023),
https://doi.org/10.2478/sjecr-2022-0030 . .

TY  - CONF
AU  - Milinković, Neda
AU  - Sarić-Matutinović, Marija
AU  - Tadić, Ivana
AU  - Dmitrašinović, Gordana
AU  - Ignjatović, Svetlana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5591
AB  - Uvod i cilj. Literaturni podaci ukazuju da serološka imunoodređivanja mogu biti adekvatna
dopuna molekularnoj dijagnostici SARS-CoV-2 infekcije. Cilj ovog ispitivanja je da se proceni
slaganje SARS-CoV-2 seroloških testova pet različitih proizvođača i ispita imuni odgovor na
različite vrste vakcina.
Metode. Korišćene su metode: Sars-CoV-2 IgG (Beckman Coulter) (I), SARS-CoV-2 ukupna
antitela (BioRad) (II), SARS-CoV-2 IgG II Quant (Abbott) (III), SARS-CoV-2 IgG (Abbott) (IV) i
Elecsys Anti-SARS-CoV-2 (Roche) (V). Paralelno je ispitivano metodom I i II 44 uzorka, I i III 84
uzorka, I i IV 53 uzorka, I i V 80 uzoraka. Dodatno je za procenu imunog odgovora na infekciju i
različite vrste vakcina analizirano 153 uzorka. Ispitanici su proveravali prisustvo antitela zbog
sumnje na asimptomatsku SARS-CoV-2 infekciju ili zbog prisustva simptoma.
Rezultati. II i III metodom je dobijen značajno veći broj reaktivnih rezultata u odnosu na I
metod (65,9% i 91,7% vs 52,3%). I i IV metode su pokazale slaganje u reaktivnosti (60,4% vs
69,8%), dok I i V metodom nije dobijeno slaganje u reaktivnosti rezultata (58,8% vs 93,8%).
Najintenzivniji imuni odgovor postignut je nakon vakcinacije Phizer vakcinom. Imuni odgovor
nakon Phizer i Sinopharm vakcine je pokazao značajnu korelaciju sa vremenom proteklim od
imunizacije (P=0,032 i P=0,012). Žene su imale značajno viši titar antitela nakon vakcinacije
u odnosu na muškarce (P=0,006). Nije dobijena značajna razlika u odnosu na tip vakcine i
godina starosti ispitanika (P=0,197).
Zaključak
Iako serološka imunoodređivanja pokazuju značajne analitičke i kliničke karakteristike za
detekciju SARS-CoV-2 i dalje postoji problem kompletne evaluacije testova i neizvesnosti u
pogledu tačnosti rezultata i njihove uporedivosti.
PB  - Udruženje farmaceuta Beograd
C3  - Simpozijum "Covid-19 infekcija-dijagnostički i prognostički biohemijski parametri", Program i zbornik sažetaka, 18.03.2022, Beograd
T1  - Analitičke i kliničke karakteristike seroloških imonoodređivanja anti-SARS-CoV-2 antitela
SP  - 12
EP  - 12
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5591
ER  - 

@conference{
author = "Milinković, Neda and Sarić-Matutinović, Marija and Tadić, Ivana and Dmitrašinović, Gordana and Ignjatović, Svetlana",
year = "2022",
abstract = "Uvod i cilj. Literaturni podaci ukazuju da serološka imunoodređivanja mogu biti adekvatna
dopuna molekularnoj dijagnostici SARS-CoV-2 infekcije. Cilj ovog ispitivanja je da se proceni
slaganje SARS-CoV-2 seroloških testova pet različitih proizvođača i ispita imuni odgovor na
različite vrste vakcina.
Metode. Korišćene su metode: Sars-CoV-2 IgG (Beckman Coulter) (I), SARS-CoV-2 ukupna
antitela (BioRad) (II), SARS-CoV-2 IgG II Quant (Abbott) (III), SARS-CoV-2 IgG (Abbott) (IV) i
Elecsys Anti-SARS-CoV-2 (Roche) (V). Paralelno je ispitivano metodom I i II 44 uzorka, I i III 84
uzorka, I i IV 53 uzorka, I i V 80 uzoraka. Dodatno je za procenu imunog odgovora na infekciju i
različite vrste vakcina analizirano 153 uzorka. Ispitanici su proveravali prisustvo antitela zbog
sumnje na asimptomatsku SARS-CoV-2 infekciju ili zbog prisustva simptoma.
Rezultati. II i III metodom je dobijen značajno veći broj reaktivnih rezultata u odnosu na I
metod (65,9% i 91,7% vs 52,3%). I i IV metode su pokazale slaganje u reaktivnosti (60,4% vs
69,8%), dok I i V metodom nije dobijeno slaganje u reaktivnosti rezultata (58,8% vs 93,8%).
Najintenzivniji imuni odgovor postignut je nakon vakcinacije Phizer vakcinom. Imuni odgovor
nakon Phizer i Sinopharm vakcine je pokazao značajnu korelaciju sa vremenom proteklim od
imunizacije (P=0,032 i P=0,012). Žene su imale značajno viši titar antitela nakon vakcinacije
u odnosu na muškarce (P=0,006). Nije dobijena značajna razlika u odnosu na tip vakcine i
godina starosti ispitanika (P=0,197).
Zaključak
Iako serološka imunoodređivanja pokazuju značajne analitičke i kliničke karakteristike za
detekciju SARS-CoV-2 i dalje postoji problem kompletne evaluacije testova i neizvesnosti u
pogledu tačnosti rezultata i njihove uporedivosti.",
publisher = "Udruženje farmaceuta Beograd",
journal = "Simpozijum "Covid-19 infekcija-dijagnostički i prognostički biohemijski parametri", Program i zbornik sažetaka, 18.03.2022, Beograd",
title = "Analitičke i kliničke karakteristike seroloških imonoodređivanja anti-SARS-CoV-2 antitela",
pages = "12-12",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5591"
}

Milinković, N., Sarić-Matutinović, M., Tadić, I., Dmitrašinović, G.,& Ignjatović, S.. (2022). Analitičke i kliničke karakteristike seroloških imonoodređivanja anti-SARS-CoV-2 antitela. in Simpozijum "Covid-19 infekcija-dijagnostički i prognostički biohemijski parametri", Program i zbornik sažetaka, 18.03.2022, Beograd
Udruženje farmaceuta Beograd., 12-12.
https://hdl.handle.net/21.15107/rcub_farfar_5591

Milinković N, Sarić-Matutinović M, Tadić I, Dmitrašinović G, Ignjatović S. Analitičke i kliničke karakteristike seroloških imonoodređivanja anti-SARS-CoV-2 antitela. in Simpozijum "Covid-19 infekcija-dijagnostički i prognostički biohemijski parametri", Program i zbornik sažetaka, 18.03.2022, Beograd. 2022;:12-12.
https://hdl.handle.net/21.15107/rcub_farfar_5591 .

Milinković, Neda, Sarić-Matutinović, Marija, Tadić, Ivana, Dmitrašinović, Gordana, Ignjatović, Svetlana, "Analitičke i kliničke karakteristike seroloških imonoodređivanja anti-SARS-CoV-2 antitela" in Simpozijum "Covid-19 infekcija-dijagnostički i prognostički biohemijski parametri", Program i zbornik sažetaka, 18.03.2022, Beograd (2022):12-12,
https://hdl.handle.net/21.15107/rcub_farfar_5591 .

TY  - CONF
AU  - Jovanović, Aleksandar
AU  - Šesto, Sofija
AU  - Odalović, Marina
AU  - Lakić, Dragana
AU  - Stević, Ivana
AU  - Krajnović, Dušanka
AU  - Tadić, Ivana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4547
AB  - Antibiotics are the gold standard in treating and preventing recurrent urinary tract
infections (UTIs), but their widespread, irrational use leads to the development of
antimicrobial resistance (1,2). The aim of this study was to analyze the use of antibiotics in
patients with UTIs symptoms. An online survey for patients was disseminated by
researchers and community pharmacists during the winter 2020/21. The study was
approved by the Ethical Committee of the University of Belgrade – Faculty of Pharmacy. The
study included 736 respondents, 31.5 years of age in average, and most of them were women
(80.8%). Approximately 40% of patients reported that they experienced symptoms of UTIs
in previous years, and 49.3% of patients did not seek a counsel of health care professionals,
and rather had used therapy following the advice of friends, family members or by their
opinion. A smaller number of patients used antibiotics in therapy (n=178, 24.2%) prescribed
by the doctor (79.2% of patients), and in some cases without prior consultation with a doctor
(20.8% of patients). Antibiotics successfully treated 70% of UTIs. According to data collected
from 133 patients, 17 different antibiotics were used in UTI treatment. The most used
antibiotics were: ciprofloxacin (23.3%), cephalexin (17.3%) and fosfomycin (14.3%).
Antibiotics used for UTIs treatment didn’t comply with the European Association of Urology
guidelines. Considering that the use of medicines could be initiated by patients and therefore
be unreported, the use of medicines for UTIs should be analysed both from clinical patients’
data records and individual patients’ reports.
AB  - Antibiotici predstavljaju zlatni standard u lečenju i prevenciji rekurentnih infekcija
urinarnog trakta (IUT), ali njihova učestala, neracionalna upotreba dovodi do razvoja
antimikrobne rezistencije (1,2). Cilj ovog istraživanja bio je da se analizira upotreba
antibiotika kod pacijenata sa simptomima IUT. Istraživači i farmaceuti u javnim apotekama
su distribuirali pacijentima onlajn anketu tokom zime 2020/21. Studiju je odobrila Etička
komisija Farmaceutskog fakulteta – Univerziteta u Beogradu. Istraživanjem je obuhvaćeno
736 ispitanika, prosečne starosti 31,5 godina, među kojima su najviše bile žene (80,8%).
Približno 40% pacijenata je izjavilo da su imali simptome IUT tokom prethodne godine, od
kojih 49,3% pacijenata nije tražilo savet zdravstvenih profesionalaca, već je koristilo terapiju
po savetu prijatelja, članova porodice ili po njihovom sopstvenom mišljenju. Manji broj
pacijenata koristio je antibiotike u terapiji (n=178, 24,2%) na osnovu lekarskog recepta
(79,2% pacijenata), a u pojedinim slučajevima i bez prethodne konsultacije sa lekarom
(20,8% pacijenata). Antibiotici su uspešno lečili 70% IUT. Prema podacima prikupljenim od
133 pacijenta, u lečenju IUT korišćeno je 17 različitih antibiotika. Najviše korišćeni
antibiotici su: ciprofloksacin (23,3%), cefaleksin (17,3%) i fosfomicin (14,3%). Antibiotici
koji su korišćeni za lečenje IUT nisu bili u skladu sa smernicama Evropskog udruženja za
urologiju. Budući da pacijenti u nekim slučajevima sami započinju terapiju bez prethodne
konsultacije sa lekarima, upotrebu lekova za IUT treba analizirati kako na osnovu kliničkih
podataka pacijenata, tako i iz izveštaja pojedinačnih pacijenata.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Antibiotic use in therapy of urinary tract infections
T1  - Upotreba antibiotika u terapiji infekcija urinarnog trakta
VL  - 72
IS  - 4 suplement
SP  - S341
EP  - S342
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4547
ER  - 

@conference{
author = "Jovanović, Aleksandar and Šesto, Sofija and Odalović, Marina and Lakić, Dragana and Stević, Ivana and Krajnović, Dušanka and Tadić, Ivana",
year = "2022",
abstract = "Antibiotics are the gold standard in treating and preventing recurrent urinary tract
infections (UTIs), but their widespread, irrational use leads to the development of
antimicrobial resistance (1,2). The aim of this study was to analyze the use of antibiotics in
patients with UTIs symptoms. An online survey for patients was disseminated by
researchers and community pharmacists during the winter 2020/21. The study was
approved by the Ethical Committee of the University of Belgrade – Faculty of Pharmacy. The
study included 736 respondents, 31.5 years of age in average, and most of them were women
(80.8%). Approximately 40% of patients reported that they experienced symptoms of UTIs
in previous years, and 49.3% of patients did not seek a counsel of health care professionals,
and rather had used therapy following the advice of friends, family members or by their
opinion. A smaller number of patients used antibiotics in therapy (n=178, 24.2%) prescribed
by the doctor (79.2% of patients), and in some cases without prior consultation with a doctor
(20.8% of patients). Antibiotics successfully treated 70% of UTIs. According to data collected
from 133 patients, 17 different antibiotics were used in UTI treatment. The most used
antibiotics were: ciprofloxacin (23.3%), cephalexin (17.3%) and fosfomycin (14.3%).
Antibiotics used for UTIs treatment didn’t comply with the European Association of Urology
guidelines. Considering that the use of medicines could be initiated by patients and therefore
be unreported, the use of medicines for UTIs should be analysed both from clinical patients’
data records and individual patients’ reports., Antibiotici predstavljaju zlatni standard u lečenju i prevenciji rekurentnih infekcija
urinarnog trakta (IUT), ali njihova učestala, neracionalna upotreba dovodi do razvoja
antimikrobne rezistencije (1,2). Cilj ovog istraživanja bio je da se analizira upotreba
antibiotika kod pacijenata sa simptomima IUT. Istraživači i farmaceuti u javnim apotekama
su distribuirali pacijentima onlajn anketu tokom zime 2020/21. Studiju je odobrila Etička
komisija Farmaceutskog fakulteta – Univerziteta u Beogradu. Istraživanjem je obuhvaćeno
736 ispitanika, prosečne starosti 31,5 godina, među kojima su najviše bile žene (80,8%).
Približno 40% pacijenata je izjavilo da su imali simptome IUT tokom prethodne godine, od
kojih 49,3% pacijenata nije tražilo savet zdravstvenih profesionalaca, već je koristilo terapiju
po savetu prijatelja, članova porodice ili po njihovom sopstvenom mišljenju. Manji broj
pacijenata koristio je antibiotike u terapiji (n=178, 24,2%) na osnovu lekarskog recepta
(79,2% pacijenata), a u pojedinim slučajevima i bez prethodne konsultacije sa lekarom
(20,8% pacijenata). Antibiotici su uspešno lečili 70% IUT. Prema podacima prikupljenim od
133 pacijenta, u lečenju IUT korišćeno je 17 različitih antibiotika. Najviše korišćeni
antibiotici su: ciprofloksacin (23,3%), cefaleksin (17,3%) i fosfomicin (14,3%). Antibiotici
koji su korišćeni za lečenje IUT nisu bili u skladu sa smernicama Evropskog udruženja za
urologiju. Budući da pacijenti u nekim slučajevima sami započinju terapiju bez prethodne
konsultacije sa lekarima, upotrebu lekova za IUT treba analizirati kako na osnovu kliničkih
podataka pacijenata, tako i iz izveštaja pojedinačnih pacijenata.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Antibiotic use in therapy of urinary tract infections, Upotreba antibiotika u terapiji infekcija urinarnog trakta",
volume = "72",
number = "4 suplement",
pages = "S341-S342",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4547"
}

Jovanović, A., Šesto, S., Odalović, M., Lakić, D., Stević, I., Krajnović, D.,& Tadić, I.. (2022). Antibiotic use in therapy of urinary tract infections. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S341-S342.
https://hdl.handle.net/21.15107/rcub_farfar_4547

Jovanović A, Šesto S, Odalović M, Lakić D, Stević I, Krajnović D, Tadić I. Antibiotic use in therapy of urinary tract infections. in Arhiv za farmaciju. 2022;72(4 suplement):S341-S342.
https://hdl.handle.net/21.15107/rcub_farfar_4547 .

Jovanović, Aleksandar, Šesto, Sofija, Odalović, Marina, Lakić, Dragana, Stević, Ivana, Krajnović, Dušanka, Tadić, Ivana, "Antibiotic use in therapy of urinary tract infections" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S341-S342,
https://hdl.handle.net/21.15107/rcub_farfar_4547 .

TY  - CONF
AU  - Jovanović, Aleksandar
AU  - Stefanović-Vojinović, Jelena
AU  - Kukić-Marković, Jelena
AU  - Petrović, Silvana
AU  - Drobac, Milica
AU  - Tadić, Ivana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4424
AB  - The use of medicinal plants has significant impact on human health (1,2). Approximately 13.000 medicinal plants are used worldwide (1), and in developing countries 65-80% of the population uses them for medicinal purposes (2). 
The aim of the study was to examine the awareness of patients in the city of Belgrade about herbal products. Quantitative, non-experimental research was conducted using a purpose-built questionnaire in public pharmacies during February 2020.
The survey involved 954 respondents, mostly women (66.5%); 39.1% of respondents aged 20-40 years. Most of the respondents were employed (65.2%), with secondary school education (45.2%). The vast majority (97.3%) used medicinal plants/herbal products, mostly occasionally, as needed (38.4%). The main motive for their use was health improvement (75.2%), while 16.2% used them to treat diseases. The primary sources of information on medicinal plants/herbal products are pharmacists (45.1%) and the media (24.2%). About a third of the respondents (37.3%) stated that they knew the difference between herbal medicinal products and dietary supplements. 52.9% of respondents claimed that herbal medicinal products are effective, but less than synthetic drugs, while 61.5% claimed that they are safe, but with certain side effects. A third of respondents (32.9%) had difficulty understanding instructions for use and they needed additional explanations. Majority (70.6%) received advice from a pharmacist when buying a herbal product.
Pharmacists are health professionals who have adequate knowledge of medicinal plants/herbal products and have a key role in advising patients in order to implement the proper use of herbal medicinal and other herbal products.

References
1. Capasso F, Gaginella TS, Grandolini G, Izzo AA. Phytotherapy: a quick reference to herbal medicine. Springer Science & Business Media. 2003.
2. Palhares RM, Gonçalves Drummond M, dos Santos Alves Figueiredo Brasil B, Pereira Cosenza G, das Graças Lins Brandão M, Oliveira G. Medicinal plants recommended by the World Health Organization: DNA barcode identification associated with chemical analyses guarantees their quality. PloS one. 2015;10(5), e0127866.

Acknowledgements
This research was conducted with help and support of Pharmacy „Lilly Drogerie“ and funded by the Ministry of Education, Science and Technological Development, Republic of Serbia through Grant Agreement with University of Belgrade-Faculty of Pharmacy No: 451-03-68/2022-14/200161.
AB  - Primena lekovitih biljaka ima značajan uticaj na ljudsko zdravlje (1,2). U svetu se
koristi oko 13 000 lekovitih biljaka (1), a u zemljama u razvoju 65-80% populacije ih
primenjuje u medicinske svrhe (2). Cilj rada bio je ispitivanje informisanosti pacijenata na
teritoriji grada Beograda o biljnim proizvodima. Sprovedeno je kvantitativno,
neeksperimentalno istraživanje pomoću namenski kreiranog upitnika u javnim apotekama
tokom februara 2020. godine. U istraživanju je učestvovalo 954 ispitanika, od koji 66,5%
ženskog pola; 39,1% starosti 20-40 godina. Većina je bila zaposlena (65,2%), sa
srednjoškolskim obrazovanjem (45,2%). Najveći broj ispitanika (97,3%) je koristio lekovite
biljke/biljne proizvode i to uglavnom povremeno, po potrebi (38,4%). Glavni motiv za
njihovo korišćenje bio je poboljšanje zdravlja (75,2%), dok ih je 16,2% koristilo za lečenje.
Ispitanici su se o delovanju i upotrebi lekovitih biljaka/biljnih proizvoda uglavnom
informisali od farmaceuta u apotekama (45,1%) i putem medija (24,2%). Oko trećine
ispitanika (37,3%) je navelo da zna razliku između biljnih lekovitih proizvoda i dijetetskih
suplemenata. Da su biljni lekoviti proizvodi efikasni, ali manje od sintetskih lekova, smatralo
je 52,9% ispitanika, dok je 61,5% smatralo da su oni bezbedni za upotrebu, ali sa mogućim
neželjenim efektima. Trećina anketiranih (32,9%) imala je poteškoće da razume uputstva za
upotrebu biljnih proizvoda, te su im bila potrebna dodatna objašnjenja. Najveći deo
ispitanika (70,6%) dobijao je savet farmaceuta pri kupovini biljnog proizvoda. Farmaceuti su
zdravstveni profesionalci koji poseduju adekvatna znanja o lekovitim biljkama/biljnim
proizvodima i imaju ključnu ulogu u savetovanju pacijenata u cilju sprovođenja pravilne
primene biljnih lekovitih i drugih biljnih proizvoda.
C3  - Arhiv za farmaciju
T1  - Awareness of patients in the city of Belgrade about herbal products
T1  - Informisanost pacijenata na teritoriji grada Beograda o biljnim proizvodima
VL  - 72
IS  - 4 suplement
SP  - S473
EP  - S474
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4424
ER  - 

@conference{
author = "Jovanović, Aleksandar and Stefanović-Vojinović, Jelena and Kukić-Marković, Jelena and Petrović, Silvana and Drobac, Milica and Tadić, Ivana",
year = "2022",
abstract = "The use of medicinal plants has significant impact on human health (1,2). Approximately 13.000 medicinal plants are used worldwide (1), and in developing countries 65-80% of the population uses them for medicinal purposes (2). 
The aim of the study was to examine the awareness of patients in the city of Belgrade about herbal products. Quantitative, non-experimental research was conducted using a purpose-built questionnaire in public pharmacies during February 2020.
The survey involved 954 respondents, mostly women (66.5%); 39.1% of respondents aged 20-40 years. Most of the respondents were employed (65.2%), with secondary school education (45.2%). The vast majority (97.3%) used medicinal plants/herbal products, mostly occasionally, as needed (38.4%). The main motive for their use was health improvement (75.2%), while 16.2% used them to treat diseases. The primary sources of information on medicinal plants/herbal products are pharmacists (45.1%) and the media (24.2%). About a third of the respondents (37.3%) stated that they knew the difference between herbal medicinal products and dietary supplements. 52.9% of respondents claimed that herbal medicinal products are effective, but less than synthetic drugs, while 61.5% claimed that they are safe, but with certain side effects. A third of respondents (32.9%) had difficulty understanding instructions for use and they needed additional explanations. Majority (70.6%) received advice from a pharmacist when buying a herbal product.
Pharmacists are health professionals who have adequate knowledge of medicinal plants/herbal products and have a key role in advising patients in order to implement the proper use of herbal medicinal and other herbal products.

References
1. Capasso F, Gaginella TS, Grandolini G, Izzo AA. Phytotherapy: a quick reference to herbal medicine. Springer Science & Business Media. 2003.
2. Palhares RM, Gonçalves Drummond M, dos Santos Alves Figueiredo Brasil B, Pereira Cosenza G, das Graças Lins Brandão M, Oliveira G. Medicinal plants recommended by the World Health Organization: DNA barcode identification associated with chemical analyses guarantees their quality. PloS one. 2015;10(5), e0127866.

Acknowledgements
This research was conducted with help and support of Pharmacy „Lilly Drogerie“ and funded by the Ministry of Education, Science and Technological Development, Republic of Serbia through Grant Agreement with University of Belgrade-Faculty of Pharmacy No: 451-03-68/2022-14/200161., Primena lekovitih biljaka ima značajan uticaj na ljudsko zdravlje (1,2). U svetu se
koristi oko 13 000 lekovitih biljaka (1), a u zemljama u razvoju 65-80% populacije ih
primenjuje u medicinske svrhe (2). Cilj rada bio je ispitivanje informisanosti pacijenata na
teritoriji grada Beograda o biljnim proizvodima. Sprovedeno je kvantitativno,
neeksperimentalno istraživanje pomoću namenski kreiranog upitnika u javnim apotekama
tokom februara 2020. godine. U istraživanju je učestvovalo 954 ispitanika, od koji 66,5%
ženskog pola; 39,1% starosti 20-40 godina. Većina je bila zaposlena (65,2%), sa
srednjoškolskim obrazovanjem (45,2%). Najveći broj ispitanika (97,3%) je koristio lekovite
biljke/biljne proizvode i to uglavnom povremeno, po potrebi (38,4%). Glavni motiv za
njihovo korišćenje bio je poboljšanje zdravlja (75,2%), dok ih je 16,2% koristilo za lečenje.
Ispitanici su se o delovanju i upotrebi lekovitih biljaka/biljnih proizvoda uglavnom
informisali od farmaceuta u apotekama (45,1%) i putem medija (24,2%). Oko trećine
ispitanika (37,3%) je navelo da zna razliku između biljnih lekovitih proizvoda i dijetetskih
suplemenata. Da su biljni lekoviti proizvodi efikasni, ali manje od sintetskih lekova, smatralo
je 52,9% ispitanika, dok je 61,5% smatralo da su oni bezbedni za upotrebu, ali sa mogućim
neželjenim efektima. Trećina anketiranih (32,9%) imala je poteškoće da razume uputstva za
upotrebu biljnih proizvoda, te su im bila potrebna dodatna objašnjenja. Najveći deo
ispitanika (70,6%) dobijao je savet farmaceuta pri kupovini biljnog proizvoda. Farmaceuti su
zdravstveni profesionalci koji poseduju adekvatna znanja o lekovitim biljkama/biljnim
proizvodima i imaju ključnu ulogu u savetovanju pacijenata u cilju sprovođenja pravilne
primene biljnih lekovitih i drugih biljnih proizvoda.",
journal = "Arhiv za farmaciju",
title = "Awareness of patients in the city of Belgrade about herbal products, Informisanost pacijenata na teritoriji grada Beograda o biljnim proizvodima",
volume = "72",
number = "4 suplement",
pages = "S473-S474",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4424"
}

Jovanović, A., Stefanović-Vojinović, J., Kukić-Marković, J., Petrović, S., Drobac, M.,& Tadić, I.. (2022). Awareness of patients in the city of Belgrade about herbal products. in Arhiv za farmaciju, 72(4 suplement), S473-S474.
https://hdl.handle.net/21.15107/rcub_farfar_4424

Jovanović A, Stefanović-Vojinović J, Kukić-Marković J, Petrović S, Drobac M, Tadić I. Awareness of patients in the city of Belgrade about herbal products. in Arhiv za farmaciju. 2022;72(4 suplement):S473-S474.
https://hdl.handle.net/21.15107/rcub_farfar_4424 .

Jovanović, Aleksandar, Stefanović-Vojinović, Jelena, Kukić-Marković, Jelena, Petrović, Silvana, Drobac, Milica, Tadić, Ivana, "Awareness of patients in the city of Belgrade about herbal products" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S473-S474,
https://hdl.handle.net/21.15107/rcub_farfar_4424 .

TY  - CONF
AU  - Vezmar-Kovačević, Sandra
AU  - Odalović, Marina
AU  - Tadić, Ivana
AU  - Vučićević, Katarina
AU  - Malenović, Anđelija
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4822
AB  - Introduction: At the Faculty of Pharmacy University of Belgrade, the Objective Structured Clinical Examination (0SCE) was introduced to assess clinical competences and communication skills of pharmacy students following their 6-weeks practice in public pharmacies during the 10th semester. Methods: The OSCE consisted of one patient case that was presented to the student firstly in a short written form. The patient case had at least one drug-related problem that the student was expected to identify and solve. A teaching assistant played the role of the patient and a teacher assessed the communication skills and clinical competences during the student's interview with the „patient" using a structured form (checklist). The student had limited time (7 minutes) to identify and solve the drug-related problem(s) and to councel the patient. The use of a Drug register and Pharmacotherapy guide were allowed. Results: One hundred fifty students completed the OSCE so far. The students could achieve O-40 points during the exam, according to their performance. The maximal point score was achieved if the student obtained all relevant information from the patient”, identified and solved the drug-related problem(s) and offered appropriate information. The minimal point score (0) was assigned if the student made an error which could harm the patient. The median result of the OSCE was 28 points (interquatile range 10), while 7 students (4.7%) scored 0-9 points, 12 (8.0%) scored 10-19 points, 68 (45.3%) scored 20-29 points, 58 (38.79%) scored 30-39 points and 5 students (3.3%) scored 40 points. Conclusions: The introduction of the OSCE was successful and enabled the teaching staff to obtain a more accurate knowledge of the students’ clinical competences and communication skills as well as to identify gaps in the competences in skills which need to be improved.
PB  - European Association of Faculties of Pharmacy
C3  - EAFP Conference 2022, Towards Pharmacy 5.0 Education - Abstract Book
T1  - Introduction of an Objective Structured Clinical Examination for Pharmacy Students in Serbia
SP  - 47
EP  - 47
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4822
ER  - 

@conference{
author = "Vezmar-Kovačević, Sandra and Odalović, Marina and Tadić, Ivana and Vučićević, Katarina and Malenović, Anđelija",
year = "2022",
abstract = "Introduction: At the Faculty of Pharmacy University of Belgrade, the Objective Structured Clinical Examination (0SCE) was introduced to assess clinical competences and communication skills of pharmacy students following their 6-weeks practice in public pharmacies during the 10th semester. Methods: The OSCE consisted of one patient case that was presented to the student firstly in a short written form. The patient case had at least one drug-related problem that the student was expected to identify and solve. A teaching assistant played the role of the patient and a teacher assessed the communication skills and clinical competences during the student's interview with the „patient" using a structured form (checklist). The student had limited time (7 minutes) to identify and solve the drug-related problem(s) and to councel the patient. The use of a Drug register and Pharmacotherapy guide were allowed. Results: One hundred fifty students completed the OSCE so far. The students could achieve O-40 points during the exam, according to their performance. The maximal point score was achieved if the student obtained all relevant information from the patient”, identified and solved the drug-related problem(s) and offered appropriate information. The minimal point score (0) was assigned if the student made an error which could harm the patient. The median result of the OSCE was 28 points (interquatile range 10), while 7 students (4.7%) scored 0-9 points, 12 (8.0%) scored 10-19 points, 68 (45.3%) scored 20-29 points, 58 (38.79%) scored 30-39 points and 5 students (3.3%) scored 40 points. Conclusions: The introduction of the OSCE was successful and enabled the teaching staff to obtain a more accurate knowledge of the students’ clinical competences and communication skills as well as to identify gaps in the competences in skills which need to be improved.",
publisher = "European Association of Faculties of Pharmacy",
journal = "EAFP Conference 2022, Towards Pharmacy 5.0 Education - Abstract Book",
title = "Introduction of an Objective Structured Clinical Examination for Pharmacy Students in Serbia",
pages = "47-47",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4822"
}

Vezmar-Kovačević, S., Odalović, M., Tadić, I., Vučićević, K.,& Malenović, A.. (2022). Introduction of an Objective Structured Clinical Examination for Pharmacy Students in Serbia. in EAFP Conference 2022, Towards Pharmacy 5.0 Education - Abstract Book
European Association of Faculties of Pharmacy., 47-47.
https://hdl.handle.net/21.15107/rcub_farfar_4822

Vezmar-Kovačević S, Odalović M, Tadić I, Vučićević K, Malenović A. Introduction of an Objective Structured Clinical Examination for Pharmacy Students in Serbia. in EAFP Conference 2022, Towards Pharmacy 5.0 Education - Abstract Book. 2022;:47-47.
https://hdl.handle.net/21.15107/rcub_farfar_4822 .

Vezmar-Kovačević, Sandra, Odalović, Marina, Tadić, Ivana, Vučićević, Katarina, Malenović, Anđelija, "Introduction of an Objective Structured Clinical Examination for Pharmacy Students in Serbia" in EAFP Conference 2022, Towards Pharmacy 5.0 Education - Abstract Book (2022):47-47,
https://hdl.handle.net/21.15107/rcub_farfar_4822 .

TY  - CONF
AU  - Ilkić, Jovana
AU  - Obradović, Dragiša
AU  - Milošević-Georgiev, Andrijana
AU  - Marinković, Valentina
AU  - Tadić, Ivana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4535
AB  - Telepharmacy impacts pharmacists’ involvement in healthcare provision and health
care outcomes (1). This service was implemented in Slovenia since September 2020 (2),
opposite to Serbia where this service is not yet implemented. The objective of this study was
to compare views of community pharmacists from Serbia and Slovenia in regards to their
understanding of the concept of telepharmacy, perceived risks and facilitators, as well as
views on overall capacity to implement such services. Semi-structured interviews with
community pharmacists were conducted in Slovenia and Serbia from October 2020 to March
2021. Interviews were transcribed ad verbatim, coded, thematically analysed and results
were compared for each major emerged theme. In total, 33 community pharmacists accepted
to participate (10 from Slovenia and 23 from Serbia). Pharmacists from both countries
expressed great interest, motivation and understanding of the concept of telepharmacy.
Participants agreed that the services should be charged and remunerated mostly by health
insurance funds, and complement the provision of pharmaceutical care in person. They both
shared doubts regarding adequacy of pharmacists’ involvement in provision of healthcare,
recognising telepharmacy as a tool to enhance it. Participants from Slovenia expressed
concerns regarding standardisation, regulations and personal data protection surrounding
telepharmacy. On the other hand, participants from Serbia believed that implementing
telepharmacy is not yet possible due to lacking regulatory, financial and organisational
infrastructure. Slovenian telepharmacy service model may present a good example for
profound understanding of facilitators, risks and barriers related to development and
implementation of a new pharmacy service in Serbia.
AB  - Telefarmacija utiče na uključenost farmaceuta u pružanje zdravstvene zaštite i ishode
u vezi sa zdravljem (1). Ova usluga je implementirana u Sloveniji od septembra 2020. godine
(2), nasuprot Srbiji gde ova usluga još nije implementirana. Cilj ove studije bio je da uporedi
stavove farmaceuta iz Srbije i Slovenije u pogledu njihovog razumevanja koncepta
telefarmacije, uočenih rizika i facilitatora, kao i stavova o ukupnom kapacitetu za uvođenje
takvih usluga. Polustrukturirani intervjui sa farmaceutima vođeni su u Sloveniji i Srbiji od
oktobra 2020. do marta 2021. Intervjui su doslovno transkribovani, kodirani, tematski
analizirani i rezultati su upoređivani za svaku već u nastalu temu. Ukupno su 33 farmaceuta
iz zajednice prihvatila učešć e (10 iz Slovenije i 23 iz Srbije). Farmaceuti iz obe zemlje iskazali
su veliko interesovanje, motivisanost i razumevanje koncepta telefarmacije. Učesnici su se
složili da usluge treba naplaćivati, i to prevashodno preko fondova zdravstvenog osiguranja,
kao i da usluge treba da dopunjuju pružanje farmaceutske zdravstvene zaštite uživo.
Učesnici su delili sumnje u adekvatnost uključenosti farmaceuta u pružanje zdravstvene
zaštite, prepoznajuć i telefarmaciju kao sredstvo za unapređenje toga. Učesnici iz Slovenije
izrazili su zabrinutost u vezi sa standardizacijom, propisima i zaštitom ličnih podataka kada
je u pitanju telefarmacija. S druge strane, učesnici iz Srbije smatraju da implementacija
telefarmacije još nije moguća zbog nedostatka regulatorne, finansijske i organizacione
infrastrukture. Slovenački model teleapotekarske usluge može predstavljati dobar primer za
duboko razumevanje facilitatora, rizika i barijera u vezi sa razvojem i implementacijom nove
apotekarske usluge u Srbiji.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Comparative analysis of pharmacists' views on telepharmacy in the Republic of Serbia and the Republic of Slovenia
T1  - Uporedna analiza stavova farmaceuta o telefarmaciji u Republici Srbiji i Republici Sloveniji
VL  - 72
IS  - 4 suplement
SP  - S313
EP  - S314
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4535
ER  - 

@conference{
author = "Ilkić, Jovana and Obradović, Dragiša and Milošević-Georgiev, Andrijana and Marinković, Valentina and Tadić, Ivana",
year = "2022",
abstract = "Telepharmacy impacts pharmacists’ involvement in healthcare provision and health
care outcomes (1). This service was implemented in Slovenia since September 2020 (2),
opposite to Serbia where this service is not yet implemented. The objective of this study was
to compare views of community pharmacists from Serbia and Slovenia in regards to their
understanding of the concept of telepharmacy, perceived risks and facilitators, as well as
views on overall capacity to implement such services. Semi-structured interviews with
community pharmacists were conducted in Slovenia and Serbia from October 2020 to March
2021. Interviews were transcribed ad verbatim, coded, thematically analysed and results
were compared for each major emerged theme. In total, 33 community pharmacists accepted
to participate (10 from Slovenia and 23 from Serbia). Pharmacists from both countries
expressed great interest, motivation and understanding of the concept of telepharmacy.
Participants agreed that the services should be charged and remunerated mostly by health
insurance funds, and complement the provision of pharmaceutical care in person. They both
shared doubts regarding adequacy of pharmacists’ involvement in provision of healthcare,
recognising telepharmacy as a tool to enhance it. Participants from Slovenia expressed
concerns regarding standardisation, regulations and personal data protection surrounding
telepharmacy. On the other hand, participants from Serbia believed that implementing
telepharmacy is not yet possible due to lacking regulatory, financial and organisational
infrastructure. Slovenian telepharmacy service model may present a good example for
profound understanding of facilitators, risks and barriers related to development and
implementation of a new pharmacy service in Serbia., Telefarmacija utiče na uključenost farmaceuta u pružanje zdravstvene zaštite i ishode
u vezi sa zdravljem (1). Ova usluga je implementirana u Sloveniji od septembra 2020. godine
(2), nasuprot Srbiji gde ova usluga još nije implementirana. Cilj ove studije bio je da uporedi
stavove farmaceuta iz Srbije i Slovenije u pogledu njihovog razumevanja koncepta
telefarmacije, uočenih rizika i facilitatora, kao i stavova o ukupnom kapacitetu za uvođenje
takvih usluga. Polustrukturirani intervjui sa farmaceutima vođeni su u Sloveniji i Srbiji od
oktobra 2020. do marta 2021. Intervjui su doslovno transkribovani, kodirani, tematski
analizirani i rezultati su upoređivani za svaku već u nastalu temu. Ukupno su 33 farmaceuta
iz zajednice prihvatila učešć e (10 iz Slovenije i 23 iz Srbije). Farmaceuti iz obe zemlje iskazali
su veliko interesovanje, motivisanost i razumevanje koncepta telefarmacije. Učesnici su se
složili da usluge treba naplaćivati, i to prevashodno preko fondova zdravstvenog osiguranja,
kao i da usluge treba da dopunjuju pružanje farmaceutske zdravstvene zaštite uživo.
Učesnici su delili sumnje u adekvatnost uključenosti farmaceuta u pružanje zdravstvene
zaštite, prepoznajuć i telefarmaciju kao sredstvo za unapređenje toga. Učesnici iz Slovenije
izrazili su zabrinutost u vezi sa standardizacijom, propisima i zaštitom ličnih podataka kada
je u pitanju telefarmacija. S druge strane, učesnici iz Srbije smatraju da implementacija
telefarmacije još nije moguća zbog nedostatka regulatorne, finansijske i organizacione
infrastrukture. Slovenački model teleapotekarske usluge može predstavljati dobar primer za
duboko razumevanje facilitatora, rizika i barijera u vezi sa razvojem i implementacijom nove
apotekarske usluge u Srbiji.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Comparative analysis of pharmacists' views on telepharmacy in the Republic of Serbia and the Republic of Slovenia, Uporedna analiza stavova farmaceuta o telefarmaciji u Republici Srbiji i Republici Sloveniji",
volume = "72",
number = "4 suplement",
pages = "S313-S314",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4535"
}

Ilkić, J., Obradović, D., Milošević-Georgiev, A., Marinković, V.,& Tadić, I.. (2022). Comparative analysis of pharmacists' views on telepharmacy in the Republic of Serbia and the Republic of Slovenia. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S313-S314.
https://hdl.handle.net/21.15107/rcub_farfar_4535

Ilkić J, Obradović D, Milošević-Georgiev A, Marinković V, Tadić I. Comparative analysis of pharmacists' views on telepharmacy in the Republic of Serbia and the Republic of Slovenia. in Arhiv za farmaciju. 2022;72(4 suplement):S313-S314.
https://hdl.handle.net/21.15107/rcub_farfar_4535 .

Ilkić, Jovana, Obradović, Dragiša, Milošević-Georgiev, Andrijana, Marinković, Valentina, Tadić, Ivana, "Comparative analysis of pharmacists' views on telepharmacy in the Republic of Serbia and the Republic of Slovenia" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S313-S314,
https://hdl.handle.net/21.15107/rcub_farfar_4535 .

TY  - CONF
AU  - Senćanski, Dejan
AU  - Marinković, Valentina
AU  - Tadić, Ivana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4534
AB  - Emotional intelligence (EI) represents a set of skills that may help in the appraisal,
expression, and effective regulation of our own emotions and the emotions of others (1).
Pharmacists’ ability to communicate positively and create bonds with patients may have an
impact on patients’ health outcomes during the provision of pharmaceutical care (2). Despite
evidence that supports the hypothesis that developing EI in healthcare professionals (HCPs)
may increase their capacity to improve patients’ health-related outcomes, little is known
about it in pharmacy practice. Our study aimed to critically appraise available data on the
potential impact of EI on pharmacy practice. The search of papers in English published
between 2000 and 2021 was performed in the PubMed, Web of Science, and Embase
databases, by defined inclusion criteria. Only four papers were selected for further analysis.
In the study on the pharmacy leadership programs, it was found that they may support the
enhancement of EI levels. Another study suggested that hospital pharmacists’ EI may
influence the reversal of the negative correlation between autistic-like traits and empathy. A
positive correlation between EI and entrepreneurial orientation was found in a study that
involved practicing community pharmacists. One of the studies emphasized pharmacists’
superiority among various HCPs in the social skills, self-motivation, and self-awareness EI
sub-domains. Further research is required to provide evidence on the potential impact of EI
and EI development programs on the pharmacy practice, and patients’ health-related
outcomes. Such studies in Serbia would add strong value to the evolution of pharmaceutical
care.
AB  - Emocionalna inteligencija (EI) predstavlja skup veština koje mogu pomoć i u proceni,
izražavanju i efikasnoj regulaciji sopstvenih emocija i emocija drugih (1). Sposobnost
farmaceuta da pozitivno komuniciraju i stvaraju veze sa pacijentima može imati uticaj na
zdravstvene ishode pacijenata tokom pružanja farmaceutske zdravstvene zaštite (ZZ) (2).
Uprkos dokazima koji podržavaju hipotezu da razvoj EI kod zdravstvenih radnika (ZR) može
povećati njihov kapacitet da poboljšaju zdravstvene ishode pacijenata, malo se o tome zna u
farmaceutskoj praksi. Naša studija je imala za cilj da kritički proceni dostupne podatke o
potencijalnom uticaju EI na farmaceutsku praksu. Pretraga radova na engleskom jeziku,
objavljenih u periodu od 2000. do 2021. godine, obavljena je u bazama podataka PubMed,
Web of Science i Embase, prema definisanim kriterijumima za uključivanje. Analizirani su
rezultati koji su prikazani u četiri naučna rada. U studiji o programima liderstva u
apotekama, utvrđeno je da oni mogu uticati na povećanje nivoa EI. Druga studija sugeriše da
EI bolničkih farmaceuta može imati pozitivan uticaj na negativne korelacije između osobina
sličnih autizmu i empatije. Pozitivna korelacija između EI i preduzetničke orijentacije
pokazana je u studiji koja je uključivala farmaceute u javnim apotekama. Jedna od studija je
istakla superiornost farmaceuta među ostalim ZR u poddomenima EI socijalnih veština,
samomotivacije i samosvesti. Potrebna su dalja istraživanja kako bi se pružili dokazi o
potencijalnom uticaju programa razvoja EI i same EI na farmaceutsku praksu i ishode u vezi
sa zdravljem pacijenata. Ovakve studije u Srbiji bi dale snažan doprinos evoluciji
farmaceutske ZZ.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - What might be an impact of emotional intelligence on pharmacy practice?
T1  - Kakav je mogući uticaj emocionalne inteligencije na farmaceutsku praksu?
VL  - 72
IS  - 4 suplement
SP  - S312
EP  - S312
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4534
ER  - 

@conference{
author = "Senćanski, Dejan and Marinković, Valentina and Tadić, Ivana",
year = "2022",
abstract = "Emotional intelligence (EI) represents a set of skills that may help in the appraisal,
expression, and effective regulation of our own emotions and the emotions of others (1).
Pharmacists’ ability to communicate positively and create bonds with patients may have an
impact on patients’ health outcomes during the provision of pharmaceutical care (2). Despite
evidence that supports the hypothesis that developing EI in healthcare professionals (HCPs)
may increase their capacity to improve patients’ health-related outcomes, little is known
about it in pharmacy practice. Our study aimed to critically appraise available data on the
potential impact of EI on pharmacy practice. The search of papers in English published
between 2000 and 2021 was performed in the PubMed, Web of Science, and Embase
databases, by defined inclusion criteria. Only four papers were selected for further analysis.
In the study on the pharmacy leadership programs, it was found that they may support the
enhancement of EI levels. Another study suggested that hospital pharmacists’ EI may
influence the reversal of the negative correlation between autistic-like traits and empathy. A
positive correlation between EI and entrepreneurial orientation was found in a study that
involved practicing community pharmacists. One of the studies emphasized pharmacists’
superiority among various HCPs in the social skills, self-motivation, and self-awareness EI
sub-domains. Further research is required to provide evidence on the potential impact of EI
and EI development programs on the pharmacy practice, and patients’ health-related
outcomes. Such studies in Serbia would add strong value to the evolution of pharmaceutical
care., Emocionalna inteligencija (EI) predstavlja skup veština koje mogu pomoć i u proceni,
izražavanju i efikasnoj regulaciji sopstvenih emocija i emocija drugih (1). Sposobnost
farmaceuta da pozitivno komuniciraju i stvaraju veze sa pacijentima može imati uticaj na
zdravstvene ishode pacijenata tokom pružanja farmaceutske zdravstvene zaštite (ZZ) (2).
Uprkos dokazima koji podržavaju hipotezu da razvoj EI kod zdravstvenih radnika (ZR) može
povećati njihov kapacitet da poboljšaju zdravstvene ishode pacijenata, malo se o tome zna u
farmaceutskoj praksi. Naša studija je imala za cilj da kritički proceni dostupne podatke o
potencijalnom uticaju EI na farmaceutsku praksu. Pretraga radova na engleskom jeziku,
objavljenih u periodu od 2000. do 2021. godine, obavljena je u bazama podataka PubMed,
Web of Science i Embase, prema definisanim kriterijumima za uključivanje. Analizirani su
rezultati koji su prikazani u četiri naučna rada. U studiji o programima liderstva u
apotekama, utvrđeno je da oni mogu uticati na povećanje nivoa EI. Druga studija sugeriše da
EI bolničkih farmaceuta može imati pozitivan uticaj na negativne korelacije između osobina
sličnih autizmu i empatije. Pozitivna korelacija između EI i preduzetničke orijentacije
pokazana je u studiji koja je uključivala farmaceute u javnim apotekama. Jedna od studija je
istakla superiornost farmaceuta među ostalim ZR u poddomenima EI socijalnih veština,
samomotivacije i samosvesti. Potrebna su dalja istraživanja kako bi se pružili dokazi o
potencijalnom uticaju programa razvoja EI i same EI na farmaceutsku praksu i ishode u vezi
sa zdravljem pacijenata. Ovakve studije u Srbiji bi dale snažan doprinos evoluciji
farmaceutske ZZ.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "What might be an impact of emotional intelligence on pharmacy practice?, Kakav je mogući uticaj emocionalne inteligencije na farmaceutsku praksu?",
volume = "72",
number = "4 suplement",
pages = "S312-S312",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4534"
}

Senćanski, D., Marinković, V.,& Tadić, I.. (2022). What might be an impact of emotional intelligence on pharmacy practice?. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S312-S312.
https://hdl.handle.net/21.15107/rcub_farfar_4534

Senćanski D, Marinković V, Tadić I. What might be an impact of emotional intelligence on pharmacy practice?. in Arhiv za farmaciju. 2022;72(4 suplement):S312-S312.
https://hdl.handle.net/21.15107/rcub_farfar_4534 .

Senćanski, Dejan, Marinković, Valentina, Tadić, Ivana, "What might be an impact of emotional intelligence on pharmacy practice?" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S312-S312,
https://hdl.handle.net/21.15107/rcub_farfar_4534 .

TY  - CONF
AU  - Tadić, Ivana
AU  - van Boven, Job
AU  - Tsiligianni, Ioanna
AU  - Potočnjak, Ines
AU  - Mihajlović, Jovan
AU  - Dima, Alexandra Lelia
AU  - Nabergoj Makovec, Urška
AU  - Ágh, Tamás
AU  - Kardas, Przemyslaw
AU  - Ghiciuc, Cristina Mihaela
AU  - Petrova, Guenka
AU  - Bitterman, Noemi
AU  - Kamberi, Fatjona
AU  - Culig, Josip
AU  - Wettermark, Bjorn
AU  - Marinković, Valentina
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4494
AB  - Medication non-adherence is recognized as a global problem associated with financial burden for patients
and healthcare funds. At the European level, different Medication Adherence Technologies (MATech) are in use. The
European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action
19132) was launched to: 1) identify current practices for Medication Adherence (MA) support by healthcare
professionals; 2) create a structure for the repository of existing MATech that could be used by different
stakeholders; and to 3) prepare guidance for sustainable implementation of MATech across European healthcare
settings. ENABLE gathered different healthcare professionals and academics from 39 countries, to achieve the set of
goals during a four-year period. Several cross-European studies were conducted employing stakeholder
consultation (Delphi) and survey methods, including analysis of current practices for assessing and supporting MA
in routine care, as well as barriers and facilitators to managing MA, work on medication management during COVID
pandemic, reimbursement pathways of adherence interventions and protocols to identify the best practices and
technologies. The MATech repository was designed by ENABLE members, and consultation of different stakeholders
is currently in progress. The repository structure includes information about the MATech product and provider,
goals and content related to managing MA, and information about the scientific evaluation and implementation. A
cross-European expert survey identified a limited number of MA enhancing interventions that are currently subject
to reimbursement. ENABLE identified the need for collaboration, infrastructure, and reimbursement to enhance the
uptake of MATech in daily practice.
AB  - Neadherenca pacijenata prema terapiji prepoznata je kao globalni problem udružen sa finansijskim
opterećenjem pojedinaca i zdravstvenih sistema. Na nivou Evrope koriste se različite tehnologije za unapređenje
adherence (Medication Adherence Technologies - MATech). Evropska mreža za razvoj najboljih praksi i tehnologija
za unapređenje adherence (ENABLE, COST Action 19132) pokrenuta je sa ciljem da se: 1) identifikuju trenutne
prakse unapređenja adherence (medication adhrerence – MA) od strane zdravstvenih profesionalaca; 2) kreira
struktura repozitorijuma postojećih MATech koju mogu da koriste različiti stejkholderi; 3) da se pripreme vodiči za
održivu implementaciju MATech širom Evrope. ENABLE okuplja zdravstvene profesionalce različitih profesija iz 39
zemalja kako bi se postigli ciljevi tokom četvorogodišnjeg perioda. Nekoliko studija u više zemalja Evrope pokrenuto
je kako bi se izvršilo ispitivanje 1) stavova različitih stejkholdera delfi metodom i upitnicima, uključujući analizu
trenutnih praksi u vezi analize i podrške MA u rutinskoj praksi, kao i barijere i facilitatore koji utiču na MA, 2)
menadžment lekovima tokom COVID pandemije, 3) načine refundacije intervencija u vezi sa MA i 4) protokola koji
identifikuju nabolje prakse i tehnologije. Kreirana je struktura MATech repozitorijuma, dok je usaglašavanje sa
različitim stejkholderima u toku. Struktura repozitorijuma zasniva se na informacijama o MATech, ciljevima i
sadržajima u vezi MA, i informacijama o naučnim procenama i implementaciji MATech. Na području Evrope
istraživanje je identifikovalo ograničeni broj intervencija za unapređenje MA koje podležu refundaciji. ENABLE
ukazuje na potrebu za kolaboracijom, razvojem infrastrukture i politike refundacije kako bi se unapredila upotreba
MATech u rutinskoj praksi.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Advancement of practice and use of medication adherence technologies
T1  - Unapređenje prakse i upotrebe tehnologija za unapređenje adherence
VL  - 72
IS  - 4 suplement
SP  - S202
EP  - S203
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4494
ER  - 

@conference{
author = "Tadić, Ivana and van Boven, Job and Tsiligianni, Ioanna and Potočnjak, Ines and Mihajlović, Jovan and Dima, Alexandra Lelia and Nabergoj Makovec, Urška and Ágh, Tamás and Kardas, Przemyslaw and Ghiciuc, Cristina Mihaela and Petrova, Guenka and Bitterman, Noemi and Kamberi, Fatjona and Culig, Josip and Wettermark, Bjorn and Marinković, Valentina",
year = "2022",
abstract = "Medication non-adherence is recognized as a global problem associated with financial burden for patients
and healthcare funds. At the European level, different Medication Adherence Technologies (MATech) are in use. The
European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action
19132) was launched to: 1) identify current practices for Medication Adherence (MA) support by healthcare
professionals; 2) create a structure for the repository of existing MATech that could be used by different
stakeholders; and to 3) prepare guidance for sustainable implementation of MATech across European healthcare
settings. ENABLE gathered different healthcare professionals and academics from 39 countries, to achieve the set of
goals during a four-year period. Several cross-European studies were conducted employing stakeholder
consultation (Delphi) and survey methods, including analysis of current practices for assessing and supporting MA
in routine care, as well as barriers and facilitators to managing MA, work on medication management during COVID
pandemic, reimbursement pathways of adherence interventions and protocols to identify the best practices and
technologies. The MATech repository was designed by ENABLE members, and consultation of different stakeholders
is currently in progress. The repository structure includes information about the MATech product and provider,
goals and content related to managing MA, and information about the scientific evaluation and implementation. A
cross-European expert survey identified a limited number of MA enhancing interventions that are currently subject
to reimbursement. ENABLE identified the need for collaboration, infrastructure, and reimbursement to enhance the
uptake of MATech in daily practice., Neadherenca pacijenata prema terapiji prepoznata je kao globalni problem udružen sa finansijskim
opterećenjem pojedinaca i zdravstvenih sistema. Na nivou Evrope koriste se različite tehnologije za unapređenje
adherence (Medication Adherence Technologies - MATech). Evropska mreža za razvoj najboljih praksi i tehnologija
za unapređenje adherence (ENABLE, COST Action 19132) pokrenuta je sa ciljem da se: 1) identifikuju trenutne
prakse unapređenja adherence (medication adhrerence – MA) od strane zdravstvenih profesionalaca; 2) kreira
struktura repozitorijuma postojećih MATech koju mogu da koriste različiti stejkholderi; 3) da se pripreme vodiči za
održivu implementaciju MATech širom Evrope. ENABLE okuplja zdravstvene profesionalce različitih profesija iz 39
zemalja kako bi se postigli ciljevi tokom četvorogodišnjeg perioda. Nekoliko studija u više zemalja Evrope pokrenuto
je kako bi se izvršilo ispitivanje 1) stavova različitih stejkholdera delfi metodom i upitnicima, uključujući analizu
trenutnih praksi u vezi analize i podrške MA u rutinskoj praksi, kao i barijere i facilitatore koji utiču na MA, 2)
menadžment lekovima tokom COVID pandemije, 3) načine refundacije intervencija u vezi sa MA i 4) protokola koji
identifikuju nabolje prakse i tehnologije. Kreirana je struktura MATech repozitorijuma, dok je usaglašavanje sa
različitim stejkholderima u toku. Struktura repozitorijuma zasniva se na informacijama o MATech, ciljevima i
sadržajima u vezi MA, i informacijama o naučnim procenama i implementaciji MATech. Na području Evrope
istraživanje je identifikovalo ograničeni broj intervencija za unapređenje MA koje podležu refundaciji. ENABLE
ukazuje na potrebu za kolaboracijom, razvojem infrastrukture i politike refundacije kako bi se unapredila upotreba
MATech u rutinskoj praksi.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Advancement of practice and use of medication adherence technologies, Unapređenje prakse i upotrebe tehnologija za unapređenje adherence",
volume = "72",
number = "4 suplement",
pages = "S202-S203",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4494"
}

Tadić, I., van Boven, J., Tsiligianni, I., Potočnjak, I., Mihajlović, J., Dima, A. L., Nabergoj Makovec, U., Ágh, T., Kardas, P., Ghiciuc, C. M., Petrova, G., Bitterman, N., Kamberi, F., Culig, J., Wettermark, B.,& Marinković, V.. (2022). Advancement of practice and use of medication adherence technologies. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S202-S203.
https://hdl.handle.net/21.15107/rcub_farfar_4494

Tadić I, van Boven J, Tsiligianni I, Potočnjak I, Mihajlović J, Dima AL, Nabergoj Makovec U, Ágh T, Kardas P, Ghiciuc CM, Petrova G, Bitterman N, Kamberi F, Culig J, Wettermark B, Marinković V. Advancement of practice and use of medication adherence technologies. in Arhiv za farmaciju. 2022;72(4 suplement):S202-S203.
https://hdl.handle.net/21.15107/rcub_farfar_4494 .

Tadić, Ivana, van Boven, Job, Tsiligianni, Ioanna, Potočnjak, Ines, Mihajlović, Jovan, Dima, Alexandra Lelia, Nabergoj Makovec, Urška, Ágh, Tamás, Kardas, Przemyslaw, Ghiciuc, Cristina Mihaela, Petrova, Guenka, Bitterman, Noemi, Kamberi, Fatjona, Culig, Josip, Wettermark, Bjorn, Marinković, Valentina, "Advancement of practice and use of medication adherence technologies" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S202-S203,
https://hdl.handle.net/21.15107/rcub_farfar_4494 .

TY  - CONF
AU  - Tadić, Ivana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4478
AB  - The global face of community pharmacy is changing. The trend in decreasing number
of healthcare professionals, and partial overlapping of their roles, lead to development of
new community pharmacy services that integrate multidisciplinary collaboration. The
community pharmacy services development is recognised in several of the International
Pharmaceutical Federation (FIP) development goals including goals for pharmacists’
education. According to the newest FIP report, community pharmacy services globally, apart
from dispensing and supply of medicines, are categorised as: 1) services involving clinical
decision-making for treatment initiation, continuation, or modification; 2) providing
medicines and pharmaceutical care beyond the pharmacy premises; 3) disease screening;
and 4) providing first aid/immediate care (1). Implementation of community pharmacy
services should be based on scientific principles to achieve their effectiveness and
sustainability. Implementation science aims to provide methods and strategies for effective
service implementation. Based on many implementation researches several
theories/frameworks were created to facilitate analysis of elements of each implementation
step: factors/determinants which influence implementation, strategies and tools for
evaluation (2). Further improvement and development of new community pharmacy
services should be guided by global trends in development of community pharmacy services
and strategies for their implementation.
AB  - Globalni izgled farmacije konstantno se menja. Trend smanjenja zdravstvenih
profesionalaca na globalnom nivou i delimično preklapanje profesionalnih uloga
zdravstvenih profesionalaca uslovljava razvoj novih farmaceutskih usluga koje često
uključuju multidisciplinarnu saradnju. Razvoj farmaceutskih usluga prepoznat je i kroz više
ciljeva razvoja farmacije postavljenih od strane Internacionalne farmaceutske federacije
(International Pharmaceutical Federation - FIP) uključujući i ciljeve za adekvatnu edukaciju
farmaceuta. Prema poslednjem izveštaju FIP farmaceutske usluge koje se pružaju na
globalnom nivou, ne uključujući usluge izdavanja i snabdevanja lekovima koje su esencijalne,
grupisane su u 4 kategorije: 1) usluge koje uključuju kliničko donošenje odluka za
započinjanje, kontinuitet i modifikaciju lečenja; 2) pružanje usluga van apoteka; 3) skrining
bolesti i 4) pružanje prve pomoći/ neposrednog zbrinjavanja pacijenata (1). Implementacija
farmaceutskih usluga treba da bude zasnovana na naučnim principima kako bi se postigla
uspešnost i održivost usluga. Nauka o implementaciji usluga ima za cilj da pruži predloge
metoda i strategija za efektivniju implementaciju. Na osnovu mnogobrojnih istraživanja
kreirane su teorije/okviri koji omogućavaju lakše sagledavanje svakog koraka
implementacije razmatrajući tri ključna elementa: faktore/ determinante koji utiču na
implementaciju, strategije i alate/ načine za procenu svakog koraka (2). Na osnovu prikaza
novih farmaceutskih usluga na globalnom nivou i načinima za efektivniju implementaciju
usluga moguće je dobiti smernice za dalji razvoj i unapređenje farmaceutskih usluga.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - International perspective on new pharmacy services
T1  - Internacionalna perspektiva u razvoju novih farmaceutskih usluga
VL  - 72
IS  - 4 suplement
SP  - S140
EP  - S141
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4478
ER  - 

@conference{
author = "Tadić, Ivana",
year = "2022",
abstract = "The global face of community pharmacy is changing. The trend in decreasing number
of healthcare professionals, and partial overlapping of their roles, lead to development of
new community pharmacy services that integrate multidisciplinary collaboration. The
community pharmacy services development is recognised in several of the International
Pharmaceutical Federation (FIP) development goals including goals for pharmacists’
education. According to the newest FIP report, community pharmacy services globally, apart
from dispensing and supply of medicines, are categorised as: 1) services involving clinical
decision-making for treatment initiation, continuation, or modification; 2) providing
medicines and pharmaceutical care beyond the pharmacy premises; 3) disease screening;
and 4) providing first aid/immediate care (1). Implementation of community pharmacy
services should be based on scientific principles to achieve their effectiveness and
sustainability. Implementation science aims to provide methods and strategies for effective
service implementation. Based on many implementation researches several
theories/frameworks were created to facilitate analysis of elements of each implementation
step: factors/determinants which influence implementation, strategies and tools for
evaluation (2). Further improvement and development of new community pharmacy
services should be guided by global trends in development of community pharmacy services
and strategies for their implementation., Globalni izgled farmacije konstantno se menja. Trend smanjenja zdravstvenih
profesionalaca na globalnom nivou i delimično preklapanje profesionalnih uloga
zdravstvenih profesionalaca uslovljava razvoj novih farmaceutskih usluga koje često
uključuju multidisciplinarnu saradnju. Razvoj farmaceutskih usluga prepoznat je i kroz više
ciljeva razvoja farmacije postavljenih od strane Internacionalne farmaceutske federacije
(International Pharmaceutical Federation - FIP) uključujući i ciljeve za adekvatnu edukaciju
farmaceuta. Prema poslednjem izveštaju FIP farmaceutske usluge koje se pružaju na
globalnom nivou, ne uključujući usluge izdavanja i snabdevanja lekovima koje su esencijalne,
grupisane su u 4 kategorije: 1) usluge koje uključuju kliničko donošenje odluka za
započinjanje, kontinuitet i modifikaciju lečenja; 2) pružanje usluga van apoteka; 3) skrining
bolesti i 4) pružanje prve pomoći/ neposrednog zbrinjavanja pacijenata (1). Implementacija
farmaceutskih usluga treba da bude zasnovana na naučnim principima kako bi se postigla
uspešnost i održivost usluga. Nauka o implementaciji usluga ima za cilj da pruži predloge
metoda i strategija za efektivniju implementaciju. Na osnovu mnogobrojnih istraživanja
kreirane su teorije/okviri koji omogućavaju lakše sagledavanje svakog koraka
implementacije razmatrajući tri ključna elementa: faktore/ determinante koji utiču na
implementaciju, strategije i alate/ načine za procenu svakog koraka (2). Na osnovu prikaza
novih farmaceutskih usluga na globalnom nivou i načinima za efektivniju implementaciju
usluga moguće je dobiti smernice za dalji razvoj i unapređenje farmaceutskih usluga.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "International perspective on new pharmacy services, Internacionalna perspektiva u razvoju novih farmaceutskih usluga",
volume = "72",
number = "4 suplement",
pages = "S140-S141",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4478"
}

Tadić, I.. (2022). International perspective on new pharmacy services. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S140-S141.
https://hdl.handle.net/21.15107/rcub_farfar_4478

Tadić I. International perspective on new pharmacy services. in Arhiv za farmaciju. 2022;72(4 suplement):S140-S141.
https://hdl.handle.net/21.15107/rcub_farfar_4478 .

Tadić, Ivana, "International perspective on new pharmacy services" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S140-S141,
https://hdl.handle.net/21.15107/rcub_farfar_4478 .

TY  - CONF
AU  - Šesto, Sofija
AU  - Tadić, Ivana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4380
AB  - Robert
Butler uveo je pojam „ i definisao ga
kao sistemsku diskriminaciju prema starijim osobama na
osnovu njihovih godina starosti 1 Starije osobe su
tokom pandemije COVID 19 bile posebno teško
pogođene i uticaj ejdžizma na njih ostavio je izvesne
posledice 2 S tim u vezi, ciljevi ovog rada bili su da se
proceni analiza stavova i stepena diskriminacije
studenata farmacije, kao budućih zdravstvenih radnika,
prema starijim osobama i da se odrede prediktori kao
faktori koji mogu biti povezani sa ejdžizmom
C3  - Konkurs za izbor najboljih naučno-istraživačkih radova studenata doktorskih akademskih studija
T1  - Ispitivanje stavova i stepena diskriminacije studenata farmacije prema starijim osobama tokom pandemije bolesti COVID 19
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4380
ER  - 

@conference{
author = "Šesto, Sofija and Tadić, Ivana",
year = "2022",
abstract = "Robert
Butler uveo je pojam „ i definisao ga
kao sistemsku diskriminaciju prema starijim osobama na
osnovu njihovih godina starosti 1 Starije osobe su
tokom pandemije COVID 19 bile posebno teško
pogođene i uticaj ejdžizma na njih ostavio je izvesne
posledice 2 S tim u vezi, ciljevi ovog rada bili su da se
proceni analiza stavova i stepena diskriminacije
studenata farmacije, kao budućih zdravstvenih radnika,
prema starijim osobama i da se odrede prediktori kao
faktori koji mogu biti povezani sa ejdžizmom",
journal = "Konkurs za izbor najboljih naučno-istraživačkih radova studenata doktorskih akademskih studija",
title = "Ispitivanje stavova i stepena diskriminacije studenata farmacije prema starijim osobama tokom pandemije bolesti COVID 19",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4380"
}

Šesto, S.,& Tadić, I.. (2022). Ispitivanje stavova i stepena diskriminacije studenata farmacije prema starijim osobama tokom pandemije bolesti COVID 19. in Konkurs za izbor najboljih naučno-istraživačkih radova studenata doktorskih akademskih studija.
https://hdl.handle.net/21.15107/rcub_farfar_4380

Šesto S, Tadić I. Ispitivanje stavova i stepena diskriminacije studenata farmacije prema starijim osobama tokom pandemije bolesti COVID 19. in Konkurs za izbor najboljih naučno-istraživačkih radova studenata doktorskih akademskih studija. 2022;.
https://hdl.handle.net/21.15107/rcub_farfar_4380 .

Šesto, Sofija, Tadić, Ivana, "Ispitivanje stavova i stepena diskriminacije studenata farmacije prema starijim osobama tokom pandemije bolesti COVID 19" in Konkurs za izbor najboljih naučno-istraživačkih radova studenata doktorskih akademskih studija (2022),
https://hdl.handle.net/21.15107/rcub_farfar_4380 .

TY  - JOUR
AU  - Senćanski, Dejan
AU  - Tadić, Ivana
AU  - Marinković, Valentina
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4210
AB  - Background: Emotional intelligence (EI) can help perceive, understand, and manage emotions and positively impact performance in any profession, including pharmacists, and consequently may have positive influence on patient-related outcomes. Although there is strong body of evidence suggesting that developing EI in health professionals (HPs) can increase their capacity to successfully communicate and build relationships with patients, thus increasing patient satisfaction, little is known about it in pharmaceutical care (PhC).

Objectives: This review aimed to synthesize available data on the probable impact of EI on PhC.

Methods: PubMed, Web of Science, and Embase databases were searched for papers in English dated between January 2000 and June 2021. Quantitative, qualitative, or mixed method studies on EI and PhC that involved practicing pharmacists were included.

Results: The inclusion criteria were met by 4 papers only. One reported positive impact of EI in reducing the negative correlation between autistic-like traits and empathy among hospital pharmacists. One study demonstrated that EI levels can be significantly enhanced through pharmacy leadership programs. Another study established a positive correlation between EI and entrepreneurial orientation in practicing community pharmacists. Higher EI scores were predictors of increased work innovation, proactivity, and risk-taking levels. One study reported comparative EI data between different HPs and found pharmacists' superiority in the EI subdomains of self-awareness, self-motivation, and social skills.

Conclusion: Additional research is required to provide evidence on how EI and EI development programs can add value to the provision of PhC. Processes and resources ought to be developed and secured to support the implementation and follow-up of such programs to bring long-term benefits to practicing pharmacists and consequently positively impacting patient-reported health outcomes.
PB  - Elsevier B.V.
T2  - Journal of the American Pharmacists Association
T1  - Emotional intelligence and pharmaceutical care: A systematic review
VL  - 62
IS  - 4
SP  - 1133
EP  - 1141
DO  - 10.1016/j.japh.2022.02.019.
ER  - 

@article{
author = "Senćanski, Dejan and Tadić, Ivana and Marinković, Valentina",
year = "2022",
abstract = "Background: Emotional intelligence (EI) can help perceive, understand, and manage emotions and positively impact performance in any profession, including pharmacists, and consequently may have positive influence on patient-related outcomes. Although there is strong body of evidence suggesting that developing EI in health professionals (HPs) can increase their capacity to successfully communicate and build relationships with patients, thus increasing patient satisfaction, little is known about it in pharmaceutical care (PhC).

Objectives: This review aimed to synthesize available data on the probable impact of EI on PhC.

Methods: PubMed, Web of Science, and Embase databases were searched for papers in English dated between January 2000 and June 2021. Quantitative, qualitative, or mixed method studies on EI and PhC that involved practicing pharmacists were included.

Results: The inclusion criteria were met by 4 papers only. One reported positive impact of EI in reducing the negative correlation between autistic-like traits and empathy among hospital pharmacists. One study demonstrated that EI levels can be significantly enhanced through pharmacy leadership programs. Another study established a positive correlation between EI and entrepreneurial orientation in practicing community pharmacists. Higher EI scores were predictors of increased work innovation, proactivity, and risk-taking levels. One study reported comparative EI data between different HPs and found pharmacists' superiority in the EI subdomains of self-awareness, self-motivation, and social skills.

Conclusion: Additional research is required to provide evidence on how EI and EI development programs can add value to the provision of PhC. Processes and resources ought to be developed and secured to support the implementation and follow-up of such programs to bring long-term benefits to practicing pharmacists and consequently positively impacting patient-reported health outcomes.",
publisher = "Elsevier B.V.",
journal = "Journal of the American Pharmacists Association",
title = "Emotional intelligence and pharmaceutical care: A systematic review",
volume = "62",
number = "4",
pages = "1133-1141",
doi = "10.1016/j.japh.2022.02.019."
}

Senćanski, D., Tadić, I.,& Marinković, V.. (2022). Emotional intelligence and pharmaceutical care: A systematic review. in Journal of the American Pharmacists Association
Elsevier B.V.., 62(4), 1133-1141.
https://doi.org/10.1016/j.japh.2022.02.019.

Senćanski D, Tadić I, Marinković V. Emotional intelligence and pharmaceutical care: A systematic review. in Journal of the American Pharmacists Association. 2022;62(4):1133-1141.
doi:10.1016/j.japh.2022.02.019. .

Senćanski, Dejan, Tadić, Ivana, Marinković, Valentina, "Emotional intelligence and pharmaceutical care: A systematic review" in Journal of the American Pharmacists Association, 62, no. 4 (2022):1133-1141,
https://doi.org/10.1016/j.japh.2022.02.019. . .

TY  - JOUR
AU  - Nabergoj Makovec, Urska
AU  - Goetzinger, Catherine
AU  - Ribaut, Janette
AU  - Barnestein-Fonseca, Pilar
AU  - Haupenthal, Frederik
AU  - Herdeiro, Maria
AU  - Grant, Sean Patrick
AU  - Jácome, Cristina
AU  - Roque, Fatima
AU  - Smits, Dins
AU  - Tadić, Ivana
AU  - Dima, Alexandra
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4098
AB  - Introduction An online interactive repository of available medication adherence technologies may facilitate their selection and adoption by different stakeholders. Developing a repository is among the main objectives of the European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE) COST Action (CA19132). However, meeting the needs of diverse stakeholders requires careful consideration of the repository structure.  Methods and analysis A real-time online Delphi study by stakeholders from 39 countries with research, practice, policy, patient representation and technology development backgrounds will be conducted. Eleven ENABLE members from 9 European countries formed an interdisciplinary steering committee to develop the repository structure, prepare study protocol and perform it. Definitions of medication adherence technologies and their attributes were developed iteratively through literature review, discussions within the steering committee and ENABLE Action members, following ontology development recommendations. Three domains (product and provider information (D1), medication adherence descriptors (D2) and evaluation and implementation (D3)) branching in 13 attribute groups are proposed: product and provider information, target use scenarios, target health conditions, medication regimen, medication adherence management components, monitoring/measurement methods and targets, intervention modes of delivery, target behaviour determinants, behaviour change techniques, intervention providers, intervention settings, quality indicators and implementation indicators. Stakeholders will evaluate the proposed definition and attributes’ relevance, clarity and completeness and have multiple opportunities to reconsider their evaluations based on aggregated feedback in real-time. Data collection will stop when the predetermined response rate will be achieved. We will quantify agreement and perform analyses of process indicators on the whole sample and per stakeholder group.  Ethics and dissemination Ethical approval for the COST ENABLE activities was granted by the Malaga Regional Research Ethics Committee. The Delphi protocol was considered compliant regarding data protection and security by the Data Protection Officer from University of Basel. Findings from the Delphi study will form the basis for the ENABLE repository structure and related activities.
PB  - BMJ Publishing Group
T2  - BMJ open
T1  - Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study
VL  - 12
IS  - 4
DO  - 10.1136/bmjopen-2021-059674
ER  - 

@article{
author = "Nabergoj Makovec, Urska and Goetzinger, Catherine and Ribaut, Janette and Barnestein-Fonseca, Pilar and Haupenthal, Frederik and Herdeiro, Maria and Grant, Sean Patrick and Jácome, Cristina and Roque, Fatima and Smits, Dins and Tadić, Ivana and Dima, Alexandra",
year = "2022",
abstract = "Introduction An online interactive repository of available medication adherence technologies may facilitate their selection and adoption by different stakeholders. Developing a repository is among the main objectives of the European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE) COST Action (CA19132). However, meeting the needs of diverse stakeholders requires careful consideration of the repository structure.  Methods and analysis A real-time online Delphi study by stakeholders from 39 countries with research, practice, policy, patient representation and technology development backgrounds will be conducted. Eleven ENABLE members from 9 European countries formed an interdisciplinary steering committee to develop the repository structure, prepare study protocol and perform it. Definitions of medication adherence technologies and their attributes were developed iteratively through literature review, discussions within the steering committee and ENABLE Action members, following ontology development recommendations. Three domains (product and provider information (D1), medication adherence descriptors (D2) and evaluation and implementation (D3)) branching in 13 attribute groups are proposed: product and provider information, target use scenarios, target health conditions, medication regimen, medication adherence management components, monitoring/measurement methods and targets, intervention modes of delivery, target behaviour determinants, behaviour change techniques, intervention providers, intervention settings, quality indicators and implementation indicators. Stakeholders will evaluate the proposed definition and attributes’ relevance, clarity and completeness and have multiple opportunities to reconsider their evaluations based on aggregated feedback in real-time. Data collection will stop when the predetermined response rate will be achieved. We will quantify agreement and perform analyses of process indicators on the whole sample and per stakeholder group.  Ethics and dissemination Ethical approval for the COST ENABLE activities was granted by the Malaga Regional Research Ethics Committee. The Delphi protocol was considered compliant regarding data protection and security by the Data Protection Officer from University of Basel. Findings from the Delphi study will form the basis for the ENABLE repository structure and related activities.",
publisher = "BMJ Publishing Group",
journal = "BMJ open",
title = "Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study",
volume = "12",
number = "4",
doi = "10.1136/bmjopen-2021-059674"
}

Nabergoj Makovec, U., Goetzinger, C., Ribaut, J., Barnestein-Fonseca, P., Haupenthal, F., Herdeiro, M., Grant, S. P., Jácome, C., Roque, F., Smits, D., Tadić, I.,& Dima, A.. (2022). Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study. in BMJ open
BMJ Publishing Group., 12(4).
https://doi.org/10.1136/bmjopen-2021-059674

Nabergoj Makovec U, Goetzinger C, Ribaut J, Barnestein-Fonseca P, Haupenthal F, Herdeiro M, Grant SP, Jácome C, Roque F, Smits D, Tadić I, Dima A. Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study. in BMJ open. 2022;12(4).
doi:10.1136/bmjopen-2021-059674 .

Nabergoj Makovec, Urska, Goetzinger, Catherine, Ribaut, Janette, Barnestein-Fonseca, Pilar, Haupenthal, Frederik, Herdeiro, Maria, Grant, Sean Patrick, Jácome, Cristina, Roque, Fatima, Smits, Dins, Tadić, Ivana, Dima, Alexandra, "Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study" in BMJ open, 12, no. 4 (2022),
https://doi.org/10.1136/bmjopen-2021-059674 . .

TY  - JOUR
AU  - Terzić, Dragana
AU  - Tadić, Ivana
AU  - Lakić, Dragana
AU  - Odalović, Marina
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4283
AB  - Healthcare  professionals  should  serve  as  promoters  of  ra-tional  antibiotic  use  in  attempt  to  decrease  antibiotics  misuse  within  the  process  of  self-medication. Current  pilot  study  was  undertaken  with  the  aim  to  identify  potential  predictors  of  self-medication with antibiotics (SMA) and to describe SMA practice among nursing students in Serbia. Data have been collected dur-ing  the  period  March-May,  2016  in  Medical  school  of  bachelor  degree, in Belgrade. Self-reported questionnaire served as a data source.  Descriptive  statistic  was  used  to  analyse  study  sample  characteristics.  Chi-square  test  was  used  to  test  differences  be-tween groups. Study sample have included 138 participants. Al-most half of them, 43.8%, practice SMA. Life style (smoking, al-cohol consumption, sleeping habits and physical activity) and so-cio-demographic  characteristics  (excepted  school  grade)  were  not  shown  as  SMA  determinants.  Time  &  money  savings  were  stated as the most frequent reason for SMA, while common cold, sore  throat  and  cough  were  the  most  common  conditions  cured  through SMA. Pharmacists’ recommendations and previous pos-itive experience were specified as the most important in the pro-cess of antibiotics selection, indicated by 50.0% and 37.5% par-ticipants,  respectively.  Amoxicillin  was  the  most  frequently  used  antibiotic in SMA, used by 50% of participants who practice SMA. High  proportion  of  SMA  and  observed  practice  among  nursing  students in Serbia call for efforts with regards to relevant educa-tion  about  rational  antibiotic  use,  actual  clinical  guidelines  and  potential consequences of misuse.
AB  - Zdravstveni  stručnjaci  bi  trebalo  da  služe  kao  pokretači  ra-cionalne  upotrebe  antibiotika  u  pokušaju  da  se  smanji  zloupo-treba  antibiotika  kroz  proces  samomedikacije.  Pilot  studija  je  sprovedena   sa   ciljem   da   se   utvrde   potencijalni   prediktori   samomedikacije  antibioticima  (SMA)  i  da  se  opiše  praksa  SMA  među studentima sestrinstva u Srbiji. Podaci su sakupljeni tokom perioda  Mart-Maj  2016,  u  Višoj  školi  strukovnih  studija  u  Be-ogradu,  Srbija.  Za  sakupljanje  podataka  korišćen  je  upitnih  za samo-popunjavanje.  U  analizi  karakteristika  ispitivanog  uzorka  korišćena je deskriptivna statistika. Hi-kvadrat test je korišćen za ispitivanje razlike između grupa. Ukupan broj učesnika u studiji bio je 138. Gotovo polovina, 43,8% je koristila SMA. Životni stil (pušenje,  konzumiranje  alkohola,  navike  u  pogledu  sna,  fizička aktivnost)   i   socio-demografske   karakteristike   (izuzev   godine   studija)  nisu  pokazane  kao  SMA.  Uštede  u  vremenu  i  novcu  su  navedene  kao  najčešći  razlog  za  SMA,  dok  su  prehlada,  upala grla  i  kašalj  najčešće  indikacije  tretirane  kroz  SMA.  Preporuke  farmaceuta  i  prethodno  pozitivno  iskustvo  su  navedeni  kao  najznačajniji faktori u odabiru antibiotika, što je tvrdilo 50,0% i 37,5% učesnika, redom. Amoksicilin je bio najčešće korišćen an-tibiotik koji je koristilo 50% učesnika kroz SMA. Visok procenat SMA  i  uočena  praksa  među  studentima  sestrinstva  u  Srbiji ukazuje na potrebe za relevantnom edukacijom u vezi sa racion-alnom  upotrebom  antibiotika,  aktuelnim  preporukama  u  klin-ičkim  vodičima  i  potencijalnim  posledicama  nepoštovanja  datih  preporuka.
PB  - University of Kragujevac, Faculty of Science
T2  - Serbian Journal of Experimental and Clinical Research
T1  - Self-medication with antibiotics among nursing students in Serbia: pilot study
T1  - Samomedikacija antibioticima među studentima sesrtinstva u Srbiji: pilot studija
VL  - 23
IS  - 3
SP  - 229
EP  - 235
DO  - 10.2478/sjecr-2019-0055
ER  - 

@article{
author = "Terzić, Dragana and Tadić, Ivana and Lakić, Dragana and Odalović, Marina",
year = "2022",
abstract = "Healthcare  professionals  should  serve  as  promoters  of  ra-tional  antibiotic  use  in  attempt  to  decrease  antibiotics  misuse  within  the  process  of  self-medication. Current  pilot  study  was  undertaken  with  the  aim  to  identify  potential  predictors  of  self-medication with antibiotics (SMA) and to describe SMA practice among nursing students in Serbia. Data have been collected dur-ing  the  period  March-May,  2016  in  Medical  school  of  bachelor  degree, in Belgrade. Self-reported questionnaire served as a data source.  Descriptive  statistic  was  used  to  analyse  study  sample  characteristics.  Chi-square  test  was  used  to  test  differences  be-tween groups. Study sample have included 138 participants. Al-most half of them, 43.8%, practice SMA. Life style (smoking, al-cohol consumption, sleeping habits and physical activity) and so-cio-demographic  characteristics  (excepted  school  grade)  were  not  shown  as  SMA  determinants.  Time  &  money  savings  were  stated as the most frequent reason for SMA, while common cold, sore  throat  and  cough  were  the  most  common  conditions  cured  through SMA. Pharmacists’ recommendations and previous pos-itive experience were specified as the most important in the pro-cess of antibiotics selection, indicated by 50.0% and 37.5% par-ticipants,  respectively.  Amoxicillin  was  the  most  frequently  used  antibiotic in SMA, used by 50% of participants who practice SMA. High  proportion  of  SMA  and  observed  practice  among  nursing  students in Serbia call for efforts with regards to relevant educa-tion  about  rational  antibiotic  use,  actual  clinical  guidelines  and  potential consequences of misuse., Zdravstveni  stručnjaci  bi  trebalo  da  služe  kao  pokretači  ra-cionalne  upotrebe  antibiotika  u  pokušaju  da  se  smanji  zloupo-treba  antibiotika  kroz  proces  samomedikacije.  Pilot  studija  je  sprovedena   sa   ciljem   da   se   utvrde   potencijalni   prediktori   samomedikacije  antibioticima  (SMA)  i  da  se  opiše  praksa  SMA  među studentima sestrinstva u Srbiji. Podaci su sakupljeni tokom perioda  Mart-Maj  2016,  u  Višoj  školi  strukovnih  studija  u  Be-ogradu,  Srbija.  Za  sakupljanje  podataka  korišćen  je  upitnih  za samo-popunjavanje.  U  analizi  karakteristika  ispitivanog  uzorka  korišćena je deskriptivna statistika. Hi-kvadrat test je korišćen za ispitivanje razlike između grupa. Ukupan broj učesnika u studiji bio je 138. Gotovo polovina, 43,8% je koristila SMA. Životni stil (pušenje,  konzumiranje  alkohola,  navike  u  pogledu  sna,  fizička aktivnost)   i   socio-demografske   karakteristike   (izuzev   godine   studija)  nisu  pokazane  kao  SMA.  Uštede  u  vremenu  i  novcu  su  navedene  kao  najčešći  razlog  za  SMA,  dok  su  prehlada,  upala grla  i  kašalj  najčešće  indikacije  tretirane  kroz  SMA.  Preporuke  farmaceuta  i  prethodno  pozitivno  iskustvo  su  navedeni  kao  najznačajniji faktori u odabiru antibiotika, što je tvrdilo 50,0% i 37,5% učesnika, redom. Amoksicilin je bio najčešće korišćen an-tibiotik koji je koristilo 50% učesnika kroz SMA. Visok procenat SMA  i  uočena  praksa  među  studentima  sestrinstva  u  Srbiji ukazuje na potrebe za relevantnom edukacijom u vezi sa racion-alnom  upotrebom  antibiotika,  aktuelnim  preporukama  u  klin-ičkim  vodičima  i  potencijalnim  posledicama  nepoštovanja  datih  preporuka.",
publisher = "University of Kragujevac, Faculty of Science",
journal = "Serbian Journal of Experimental and Clinical Research",
title = "Self-medication with antibiotics among nursing students in Serbia: pilot study, Samomedikacija antibioticima među studentima sesrtinstva u Srbiji: pilot studija",
volume = "23",
number = "3",
pages = "229-235",
doi = "10.2478/sjecr-2019-0055"
}

Terzić, D., Tadić, I., Lakić, D.,& Odalović, M.. (2022). Self-medication with antibiotics among nursing students in Serbia: pilot study. in Serbian Journal of Experimental and Clinical Research
University of Kragujevac, Faculty of Science., 23(3), 229-235.
https://doi.org/10.2478/sjecr-2019-0055

Terzić D, Tadić I, Lakić D, Odalović M. Self-medication with antibiotics among nursing students in Serbia: pilot study. in Serbian Journal of Experimental and Clinical Research. 2022;23(3):229-235.
doi:10.2478/sjecr-2019-0055 .

Terzić, Dragana, Tadić, Ivana, Lakić, Dragana, Odalović, Marina, "Self-medication with antibiotics among nursing students in Serbia: pilot study" in Serbian Journal of Experimental and Clinical Research, 23, no. 3 (2022):229-235,
https://doi.org/10.2478/sjecr-2019-0055 . .